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1.1 Biocatalysis :  a green tool in organic chemistry 
Advances in both chemical catalysis and biocatalysis are determinants in reducing the 
environmental footprint of chemical processes. In the field of chemical catalysis (i.e. using 
catalysts of nonbiological origin) the principle of environmental catalysis is well established 
and has been accepted for decades, producing excellent research on how to decrease, 
catalytically, the amounts of contaminants. 
In this context, biocatalysis, intended as the use of whole cells or enzymes for the catalysis of 
chemical reactions, fully participates in the “green chemistry” concept that was introduced in 
the 90s1, and its effect on sustainability is now established beyond question.  
The term “Green chemistry” was first coined by the US Environmental Protection Agency.  
“Green chemistry” is defined as the design, development, and application of chemical 
processes and products to reduce or eliminate the use and generation of substances that can 
be hazardous to human health and environment.2,3 However, “Green chemistry” is not just 
about industrial production but essentially a way of thinking. It involves pulling together 
tools, techniques and technologies that can help chemists and chemical engineers in research, 
development and production to develop more eco-friendly and efficient products and 
processes, which may also have significant financial benefits. 
The principles involved apply equally to the use of chemicals in laboratories and education. In 
practice “Green chemistry” embraces concepts such as: 
 
 Atom efficiency - designing processes to maximise the amount of raw material that is 
converted into the product. 
 
 Energy conservation – designing more energy efficient processes. 
 
 Waste minimisation - recognising that the best form of waste disposal is not to create 
waste in the first place. 
 
 Substitution - using safer, more environmentally benign raw materials and solvents or 
solvent free processes. 




(1)  Prevent waste: Design chemical syntheses to prevent waste, leaving no waste to treat or 
clean up. 
(2)  Design safer chemicals and products: Design chemical products to be fully effective, yet 
have little or no toxicity.  
(3)  Design less hazardous chemical syntheses: Design syntheses to use and generate 
substances with little or no toxicity to humans and the environment. 
(4)  Use renewable feedstock: Use raw materials and feedstocks that are renewable rather 
than depleting. Renewable feedstocks are often made from agricultural products or are 
the by-products of other processes; depleting feedstocks are made from fossil fuels 
(petroleum, natural gas, or coal) or are mined. 
(5) Use catalysts, not stoichiometric reagents: Minimise waste by using catalytic reactions. 
Catalysts are used in small amounts and can carry out a single reaction many times. They 
are preferable to stoichiometric reagents, which are used in excess and work only once. 
(6) Avoid chemical derivatives: Avoid using blocking or protecting groups or any temporary 
modifications if possible. Derivatives use additional reagents and generate waste. 
(7)  Maximise atom economy: Design syntheses so that the final product contains the 
maximum proportion of the starting materials. There should be few, if any, wasted atoms. 
(8)  Use safer solvents and reaction conditions: Avoid using solvents, separation agents, or 
other auxiliary chemicals. If these chemicals are necessary, use innocuous chemicals. If a 
solvent is necessary, water is a good medium as well as certain eco-friendly solvents that 
do not contribute to smog formation or destroy the ozone layer. 
(9) Increase energy efficiency: Run chemical reactions at ambient temperature and pressure 
whenever possible. 
(10)  Design chemicals and products to degrade after use: Design chemical products to break 
down to innocuous substances after use so that they do not accumulate in the 
environment.  
(11)  Analyse in real time to prevent pollution: Include in-process real-time monitoring and 
control during syntheses to minimise or eliminate the formation of by-products. 
(12)  Minimise the potential for accidents: Design chemicals and their forms (solid, liquid, or 
gas) to minimise the potential for chemical accidents including explosions, fires, and 
releases to the environment. 
 
Figure 1 - Twelve principles of green chemistry1 
 
Biocatalysts constitute a green alternative to traditional organic synthesis, offering 
appropriate tools for the industrial transformation of natural or synthetic materials under 
mild reaction conditions, low energy requirements and reducted problems of isomerisation 
and rearrangement.4-7 In addition, biocatalysts are biodegradable and may display chemo-, 
regio- and stereo-selectivity resulting in decreased by-product formation and avoiding the 
need for functional group activation, protection or deprotection. Large-scale industrial 
applications of biocatalysis include for example the thermolysin-catalyzed synthesis of the 
low calorie sweetener aspartame, the production of acrylamide and nicotinamide assisted by 
nitrile hydratases, the synthesis of isomaltulose – a non cariogenic sweetener - by sucrose 




Figure 2 - Examples of molecules manufactured using  
large-scale industrial applications of biocatalysts. 
 
Good examples of the replacement of traditional organic processes by a “greener” biocatalytic 
alternative are the industrial synthesis of semisynthetic penicillins and cephalosporins10, the 
transformation of natural and synthetic fibres11, the pulp kraft-bleaching and recycling of 
paper12, and the development of pharmaceutical intermediates.13 
An example of the impact of biocatalysis14 on chemical manufacturing is a process recently 
launched by a Company for the manufacture of atorvastatin, a key ingredient in the 
cholesterol-lowering drug.   
 
Figure 3 –Atorvastatin 
 
They focused on the impact of the biocatalytic step to produce a key advanced intermediate in 
the manufacture of atorvastatin (Fig.3). 
 
 
Scheme 1 – Chemical route to the key diol precursor of atorvastatin 
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Scheme 2 – Biocatalytic route to the key diol precursor of atorvastatin 
 
Table 1 shows the comparative data from both the chemical and biocatalytic processes. The 
enzymatic process operates at higher concentration with approximately 1% catalyst loading. 
In addition, the expense and energy of cryogenic conditions is avoided. Another important 
advantage of the biocatalytic process is the large reduction in solvent required – the 
biocatalytic process uses almost 90% less solvent than the chemical process, resulting in far 
lower waste generation. The process is not only greener and lower in cost but it  produces a 
purer product. Top conversion is near 100% of theoretical, with perfect stereochemical purity. 
 
Parameter Enzymatic Process Chemical Process 
Crude substrate load 300 g/L 100 g/L 
Substrate / Catalyst (wt/wt) 100:1 1:1 
Conversion 99,3% Not provided 
Diastereomeric excess 99,99% ~94% 
Cryogenic reaction cond. required No Yes 
Solvent use 3,2 L/kg 27,5 L/kg 
 
Table 1Comparison of the biocatalytic and chemical processes for the production of atorvastatin precursor. 
 
 
1.2  Enzymes in organic chemistry 
1.2.1 Introduction 
During the last two decades the general opinion about the use of enzymes in organic 
reactions has changed. In fact, some years ago, conventional biocatalysis had mainly been 
performed in aqueous solutions. Enzymes were considered to be most active in water and 
organic solvents were thought to destroy their catalytic activity.  
This view was radically changed in the late 70s and early 80s by reports of enzymes used in 
organic media15,16 and particularly by the publications by Klibanov who showed that lipases 
were highly active and stable in different organic solvents at low water concentrations. There 
are several advantages of conducting enzymatic conversions in organic solvents as opposed to 
water. Most organic compounds are more soluble in non aqueous media than in an aqueous 
one and the biocatalytic step is more easily integrated into a chemical process. Further, 
unwanted side reactions caused by water can be reduced and the equilibrium in hydrolytic 
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reactions can be shifted towards synthesis.17-19 Since these pioneering work20,21 many 
publications have appeared on enzyme catalyzed kinetic resolutions in organic solvents, 
especially lipase catalyzed reactions22 and on related topics like the use of organic co-
solvents23 in water, reactions in solvent-free medium24 or in compressed or supercritical 
gases25, and the addition of salts26 or (thia)crown ethers to the lipase.27 
The use of enzymes in organic synthesis starts with the search for a selective enzyme for a 
certain reaction. Enzyme screening28 is a route to enantioselective enzymes. A change in 
enzyme stereoselectivity can in principle be achieved by protein engineering.29 However, by 
changing the reaction conditions (solvent, temperature, pressure) the enantioselectivity of 
enzymes can often be improved in a simpler manner. A no selective enzyme in one solvent 
may become a useful selective catalyst in another solvent. Sometimes, changing the solvent 
can even cause a reversal of enzyme enantioselectivity.30 Attempts to correlate the 
enantioselectivity with physical characteristics of the solvents like dipole moment, dielectric 
constant, and hydrophobicity can be found in several papers.31,32 
Water is absolutely necessary for the catalytic function of enzymes, because water 
participates, directly or indirectly, in all no covalent interactions that maintain the 
conformation of the catalytic site of enzymes. Hence, removal of all water from the enzyme 
should drastically distort its conformation and result in deactivation of the enzyme. However, 
only a minimal amount of water is necessary around the enzyme molecules, and as long as 
this layer of essential water is present, replacement of the rest of the water by an organic 
solvent should be possible without unfavorably affecting the enzyme. The amount of water 
available for the enzyme is best quantified by the thermodynamic water activity aw.33 The 
water activity can be controlled by addition of molecular sieves or mixtures of salt hydrates. 
In this way the influence of the solvents can be studied separately from their ability to strip 
water from the enzyme.34 In synthetic organic chemistry commercially available freeze dried 
samples of lipases (containing a minimal amount of water) are probably the most accessible 
enzymes to use in organic solvents. 
The nature of the solvent is crucial for maintaining the layer of essential water around the 
enzyme. The most hydrophobic solvents, such as hydrocarbons, are the most suitable for this 
purpose because in these solvents the essential water isn’t stripped from the enzyme 
molecules.  
1.2.2 Kinetic reasons that govern the selectivity 
In a catalyzed process an enzyme (E) accelerates a reaction lowering  the energy barrier  
between substrate (S) and product (P): energy activation (Ea). This is attributed to the 











S=substrate, P=product, E=enzyme, 
[ES]=enzyme-substrate complex, 




In theory all the stereoselectivity of enzymes originates from the difference in energy 
enzyme-transition state [ES]≠ (Fig. 5). For example, in a enantioselective reaction, the two 
enantiomers A  and B or the two forms of a mirror oriented prochiral substrate (involving its 
faces or its enantiotopic groups) may compete for the active site: enzyme-substrate complexes 
formed diastereoisomeric [EA] and [EB] have different  values of free energy (∆G) for the 
respective transition states [EA]≠ and [EB]≠. An enantiomer (or a particular orientation of a 











E=enzyme,  A-B= enantiomeric substrates, P-Q= enantiomeric 
products, [EA]- [EB]=enzyme-substrate complex, ∆∆G, ∆∆H, 
∆∆S= Free energy, enthalpy and entropy variation R = gas costant, 





The value of  ∆∆G≠ is of great importance because it determines the optical purity of product: 
the enthalpy of activation is usually dominated by the breaking and formation of ties when 
the substrate is transformed into the product. The entropic contribution includes energy 
balance resulting from the order of the system, as the orientation of the reagents, 
conformational changes during the approach to the active site and effects of solvation. 
 
1.2.3 Advantages and drawbacks of biocatalysts 
The approach to organic reactions catalyzed by enzymes are often accompanied by the 
assumption that enzymes are expensive. Some enzymes are indeed expensive, but many are 
produced cheaply on a large scale. Considering their high catalytic power and the fact that 
they are recyclable
35 
most reasonably price crude enzyme preparations are adequate when 
compared to chemical catalysts.  
However, the following advantages can be listed:  
– ‘Enzymes are very efficient catalysts’. Compared to their non-enzymatic reactions, enzyme-




, far out seeding those of chemical 
catalysts. Consequently, whereas chemical catalysts are generally employed in concentrations 
of mole percentage 0.1-1%, enzymatic reactions can be performed at reasonable rates with 
mole percentage of 0.001-0.0001%.  
– ‘Enzymes are environmentally acceptable.’ Biocatalysts are environmentally benign reagents 
since they are completely degradable, unlike heavy metals.  
– ‘Enzymes act under mild conditions.’ Enzymes act in a pH range of about 5-8, typically around 
7, and in a temperature range of 20-40°C, preferably around 30°C. This minimizes undesired 
side-reactions
36 
which often plague traditional methodology.  
– ‘Enzymes are compatible with each other. Since enzymes normally function under similar 
conditions, biocatalytic reaction can be carried out in tandem making sequential reactions 
feasible in multienzyme synthetic methodology, particularly if isolation of unstable 
intermediates is not always possible.  
– ‘Enzymes are not bound to their natural role.’ Enzymes can tolerate a large variety of man-
made unnatural substrates. Often, aqueous medium can be replaced by an organic solvent. 
– ‘Enzymes can catalyze a broad spectrum of reactions.’
 
There’s an enzyme-catalyzed process 
equivalent to almost every type of organic reaction. For example, as we have been previously 
described common examples range from:  
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(a) Hydrolysis-synthesis of esters, amides, lactones, lactams, ethers, acid anhydrides, 
epoxides and nitriles.  
(b) Oxidation-reduction of alkanes, alkenes, aromatics, alcohols, aldehydes and ketones, 
sulfides and sulfoxides.  
(c) Addition-elimination of water, ammonia, hydrogen cyanide.  
(d) Halogenation and dehalogenation, alkylation and dealkylation, carboxylation and 
decarboxylation, isomerization, acyloin and aldol reactions. Even Michael-additions, 
Diels-Alder and Claisen-rearrangement reactions have been reported.  
Enzymes display three major types of selectivities:  
– Chemoselectivity. Since enzymes tend to act on a single type of functional group, other 
sensitive functionalities that are sensitive to chemical catalysis do survive. Thus, reactions 
tend to be cleaner and laborious purification can be largely omitted.  
– Regioselectivity and Diastereoselectivity. The complexity of an enzyme’s three dimensional 
structure affords an enzyme to distinguish between functional groups which are situated in 
different regions of the same substrate molecule.
32,33
 
– Enantioselectivity. Since all enzymes are made from L-amino acids, they are thus chiral 
catalysts. Consequently, chirality present within a substrate molecule is ‘recognized’ upon 
enzyme-substrate complex formation. A prochiral substrate, as a consequence, may be 
transformed into an optically active product through asymmetrization and both enantiomers 
of a racemic substrate may react at different rates, affording a kinetic resolution. Collectively, 
these properties constitute the ‘specificity’ of an enzyme and represents its most important 
feature for selective and asymmetric exploitation.
37-47
  
On the contrary, there are certainly drawbacks to the use of biocatalysis:  
– ‘Enzymes are provided by Nature in only one enantiomeric form.’ Since there’s no general way of 
creating mirror-image enzymes, it is impossible to invert the chiral induction of a given 
enzymatic reaction by choosing the ‘other enantiomer’ of the biocatalyst, a strategy possible if 
chiral chemical catalysts are involved.  
– ‘Enzymes require narrow operation parameters.’ Working under mild reaction conditions can 
certainly have its drawback. For example, if a reaction has a narrow window of operation at a 
given pH and temperature, elevated temperature, extreme pH or even high salt concentration 
may deactivate the enzyme. Some enzymes, however, remain catalytically active even in ice.
48
 
Most enzymes sensitive to temperature but if certain precautions are met, enzymes are 
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remarkably stable. Some are known to tolerate hostile environments such as temperature 
greater then 100
o
C and pressures beyond several hundred bar.
40,41
 
– ‘Enzymes display their highest catalytic activity in water.’ Enzymes display their highest 
catalytic activity in water, but the majority of organic compounds are only poorly soluble. 
Providing certain guidelines are followed, enzymes can function in organic solvents. 
Although low activity may be expected, other advantages can be accrued.
41-44
 
– ‘Enzymes are bound to their natural cofactors.’ Although enzymes are extremely flexible in 
accepting non-natural substrates, they are almost exclusively bound to their natural 
cofactors. The majority of these ‘biological reagents’ are relatively unstable molecules and are 
prohibitively expensive when used in stoichiometric amounts. Unfortunately, they cannot be 
replaced by more economical man-made substitute.
38
 
– ‘Enzymes are prone to inhibition phenomena.’ The efficiency of a reaction may be limited if the 
enzymatic reactions are prone to substrate or product inhibition. Whereas substrate 
inhibition can be circumvented easily by keeping substrate concentration low, product 
inhibition is a little more complicated.  
– ‘Enzymes may cause allergic reactions.’ Enzymes may cause allergic reactions but careful 
handling may minimize reaction. 
In conclusion, many factors make enzymes especially attractive for organic synthesis, 
although there are still certain restrictions in their applicability. We can expect that with the 
progress of technology, some of the limitations will be overcome in the near future by using 
novel (genetically engineered) enzymes and through the development of novel techniques.  
 
1.2.4 Biotransformations in organic chemistry 
The use of enzymes for the biotransformation of non-natural organic compounds is not at all 
new as they have been used for about a century. What has changed, however, is the objective; 
that is, ‘biocatalysis’ has evolved as a trend-setting segment of organic synthesis since the 
mid-eighties thus providing a powerful tool to the arsenal of modern organic synthesis. 
Whereas most of the early studies were directed towards the elucidation of biochemical 
pathways and enzyme mechanisms, the enormous potential for employing enzymes to 
transform non-natural organic compounds was only realized relatively recently, i.e. during 
the late 1980´s. As a result of this intense research, enzymes have been secured an important 




Much of the early research was impeded by a tacitly accepted dogma which stated that 
enzymes are Nature´s own catalysts developed during evolution for the regulation of metabolic 
pathways. This narrow definition implied that man-made or non-natural organic compounds 
cannot be regarded as substrates. However, once this pedagogic problem was attacked by 
non-traditionalists, it was quickly shown that the substrate tolerance of enzymes is much 
wider than believed. An impressive number of biocatalysts have been shown to possess a wide 
substrate tolerance by keeping their exquisite catalytic properties with respect to chemo-, 
regio- and, most importantly, enantio-selectivity.
54 
For many of these enzymes, the natural 
substrates - if there are any - are not known. As a consequence, the frequency of use of a 
particular enzyme is not evenly distributed among the various types of biocatalysts but 


















Frequency of use of enzymes in biotransformations; (i) Ester formation, -aminolysis, -hydrolysis; (ii) ester 
hydrolysis; (iii) ester and amide hydrolysis, peptide synthesis; (iv) nitrile hydrolysis; (v) hydrolysis of epoxides, 
halogens, phosphates, glycosylation; (vi) reduction of aldehydes, ketones and enoates; (vii) biohydroxylation, 
sulfoxidation, epoxidation, Baeyer-Villiger oxidation, dihydroxylation; (viii) cyanohydrin formation, acyloin and 
aldol reaction; (ix) glycosyl transfer; (x) Claisen-type rearrangement, isomerization of carbohydrates, 
racemization and epimerization. 
 
 
The field of industrial enzymes is now experiencing major R&D initiatives, resulting in both 
the development of a number of new products and in improvement in the process and 
performance of several existing products. According to a report from Business 
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Communications Company, Inc. the global market for industrial enzymes was estimated at $2 
billion in 2004. 
With the increased awareness of environment and cost issues, biotechnology is gaining 
ground rapidly due to the various advantages that it offers over conventional technologies.  
Lipolytic enzymes are currently attracting an enormous attention because of their 
biotechnological potential.63 They constitute the most important group of biocatalysts for 
biotechnological applications.  
Novel biotechnological applications have been successfully established using lipases for the 
synthesis of biopolymers and biodiesel, the production of enantiopure pharmaceuticals, 
agrochemicals, and flavour compounds.64 
 
1.2.5 Lipases  
Enzymes are classified according to the type of the catalyzed reaction, and lipases (3.1.1.3) 
are a sub-class of enzymes within the esterase family whose natural function is to hydrolyse 




Enzymatic hydrolysis of a triglyceride into fatty acids and glycerol. 
 
 
Lipases are among the most commonly used enzymes in organic synthesis because of their 
stability, availability, and acceptance of a broad range of substrates.65 They are found widely 
in nature in microorganisms 66-68, animals 69,70 and plants71 where their function is to digest 
lipids in order to make these available as an energy source for the cells. Fungi and bacteria 
secrete lipases to their surroundings to facilitate nutrient absorption from the external 
medium. There are many potential applications of lipases as can be seen in Table 3, as in 
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leather processing, animal feed, pulp and paper processing, etc. 72, however the most 
significant industrial applications of lipases have mainly been found in the pharmaceutical 
sector, in food and in detergents.73 One very useful trait of lipases is their enantioselectivity; 
this is exploited in the pharmaceutical industry where lipases are used for the preparation of 
single-isomer chiral drugs, either by kinetic resolution of racemic alcohols, acids, esters or 


















Lipases are prepared either by extraction from animal or plant tissue, or by cultivation of 
microorganism. Commercially available lipases are usually derived from microorganisms 
although there are some difficulties because many organisms produce mixtures of lipase 
isoforms which differ only marginally, for example by their glycosilation pattern. 
Limited proteolysis during maturation of a prolipase or during recovery may result in a 
heterogeneous mixture of enzymes with lipolytic activity, and ambiguities may exist in the 
taxonomic classification of the producing microorganism (table 4). 
INDUSTRY PRODUCTS FUNCTION 
 Cocoa butter equivalent Trans esterification 
 Human milk fat substitute Trans esterification 
Food Mono/diacyl glycerol Emulsifier 
 Cheese Flavour development 
 Bread Dough stability and conditioning 
   
Cosmetics Fatty acid ester Emollient 
   
Detergent Stain removal Lipid degradation 
   
Leather Degreasing  Lipid degradation 
   
Paper Pitch control,  Lipid degradation 
   
Organic synthesis  Resolution of chiral alcohols and amide 
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Lipase source Remarks 
Candida rugosa An organism that was formerly classified as Candida cylindracea. Protein 
purification and cloning of the enzyme revealed that the organism produces at 
least five related lipase isoforms. 
Geotrichum candidum Contains two isoforms differing in specificity towards ∆9-unsaturated fatty acids. 
Penicilium 
camambertii 
Classified as lipase from P.cyclopium until 1990. Contains four lipase isoforms 
which differ in their glycosilation pattern 
Pseudomonas cepacia Reclassified in 1995 ad Burkholderia cepacia. Cloning and sequencing revealed 
identity with lipase from Pseudomonas sp. ATCC21808. 
 
Table 4 
Some of ambiguities concerning commercially available lipases. 
 
 
Fortunately, many pure lipases, often obtained by recombinant technology, can now be 
purchased from enzyme suppliers. In table 5 are presented commercially lipases.  
 
 
Origin Specificity Applications 
Mammalian origin   
Human pancreatic lipase sn-1,3  
Human gastric lipase sn-1,3 (acid stable)  
Porcine pancreatic lipase sn-1,3 
Organic synthesis, digestive 
aid 
Guinea pig pancreatic lipase sn-1,3 (phospholipase A1 activity)  
Fungal origin   
Candida rugosa nonspecific Organic synthesis 
Candida antarctica B sn-1,3 Organic synthesis 
Geotrichum candidum cis-∆9 (unsaturated fatty acids) Oleochemistry 
Humicola lanuginosa nonspecific Detergents 
Rhizomucor miehei sn-1,3 Cheese manufactoring 
Aspergillus oryzae  Cheese manufactoring 
Penicilium camambertii sn-1,3 Monoglycerides 
Rhizopus oryzae sn-1,3 (phospholipase A1 activity) Oleochemistry 
Bacterial origin   
Pseudomonas glumae nonspecific Organic synthesis, detergents 
Burkholderia cepacia nonspecific Organic synthesis 
Chromobacterium viscosum sn-1,3 Organic synthesis 
 
Table 5 
Important commercially available lipases. 
 
Common to all lipases is the α/β− hydrolase fold structure, which means that the enzyme is 










The folding pattern arranges the residues of the catalytic triad of His-Asp-Ser76 so that the 
nucleophilic serine rests at a hairpin turn between a β-strand and an α-helix.77 
In figure 10, is represented the general mechanism of hydrolisis reactions by lipase enzyme, 























In a) it’s shown the mechanism of action of a lipase to break the ester bond. After the 
substrate was anchored in the oxoanion hole  (carbonyl oxygen site on the two remaining-
NH), serine attacks the carbonyl nucleophilic to form the tetrahedral intermediate (b). The 
tetrahedral intermediate decomposes in acyl-enzyme (c). Then, the alcohol group formed by 
the enzyme is released and replaced with a water molecule  that attacks the acyl-enzyme 







(e) to that of the intermediate tetrahedral formation, resulting in the release of the carboxy 
group with the concomitant regeneration of free enzyme (f). 
To understand the molecular basis of substrate specificity, Schmid and co-workers analysed 
and compared six lipases with different substrate specificities for the acyl group.79 
It was found that the lipases have a large, hydrophobic fatty acid binding site but that differ in 
the geometry of their binding sites. The lipases were subdivided into three sub-groups:  
1. lipases with a hydrophobic, crevice-like binding site located near the protein surface 
(lipases from Rhizomucor and Rhizopus);  
2. lipases with a tunnel-like binding site (lipase from Candida rugosa); 
3. lipases with a funnel-like binding site (lipases from Candida antarctica, Pseudomonas and 
mammalian pancreas and cutinase). 
The shape and micro-environment of the binding site determine the substrate specificity of 
the lipase.  
The reaction rate and enantioselectivity of enzymatic reactions are affected by the reaction 
temperature. In general, enhanced temperatures cause an increase in catalytic activity, but at 
a certain temperature the enzyme can become completely deactivated.  Denaturation of 
proteins may be expected between 30 and 80ºC and often leads to irreversible aggregation. 
Another problem with increasing temperature is the decrease in enantioselectivity. This is 
caused by the increasing mobility of the protein segments and the decreasing strength of 
hydrophobic interactions.80   However, there are certain enzymes that are still very active at 
very high (and very low) temperatures and enantioselectivities can still be very high. In 
particular several lipases are found to withstand rather high temperatures.81  
A way of increasing the (thermal) stability of lipases can be by immobilization.82 However, the 
use of immobilized lipases in organic solvents has many other advantages compared to their 
use in powder form83,84  
-  Lipases are less sensitive to denaturation and therefore the observed reaction rate is 
increased. 
-  Immobilization by adsorbing the enzymes onto solid matrices leads to a higher surface 
area to volume ratio and the enzyme-substrate interaction may be improved.  
-  Their recovery is facilitated. 





1.2.6 Candida antarctica lipase B 
In the work covered in this thesis the lipase B from the yeast Candida antarctica has been 
mainly used because it resulted more efficient in lactonization than other lipases. C. antarctica 
was, as the name implies, originally found on Antarctica, isolated from a hypersaline lake 
called Vanda.85 The yeast expresses two lipases: lipase A (CALA) and lipase B (CALB).86 
CALB consists of 317 amino acid residues which are folded into a globular α/β type protein 
with the dimensions of 30Å x 40Å x 50Å.  
CALB shares the common catalytic triad Ser-Asp-His of other lipases, however it differs from 
the typical lipase in that it is not activated by interfaces. The optimal pH of CALB is 7, 
however the enzyme is stable in the range of pH 3.5-9.5 87 and it shows an unusual pH profile 
with a broad isoelectric region ranging from pH 4 to 8.88 X-ray crystallography has revealed 
that the active site of CALB is composed of two channels, one hosting the acyl group, and the 
other hosting the nucleophile.89 The channels are described as deep and narrow. This has 
implications for the selectivity and specificity of the enzyme, which is known to be highly 
enantioselective and only accepting rather non-bulky substrates, especially for the 
nucleophilic substrate.90 Substrates are however not only restricted to the natural substrates 
fatty acids, water and glycerol; straight-chain primary alcohols are very good substrates for 
CALB and some secondary alcohols are also accepted as substrates while tertiary alcohols are 
not accepted.87 Along with alcohols, also hydrogen peroxide and amines works as 





To improve the industrial production efficiency, CALB is expressed in Aspergillus oryzae 
by submerged fermentation (http://www.novozymes.com). Usually CALB is used in its 
immobilised form on a macroporous acrylic resin (Lewatit VP OC 1600). In this shape it is 
marketed by Novozymes A/S as Novozym®435 (Fig. 13) and by Roche Molecular 
Biochemicals as Chirazyme L-2.  
 22 
The temperature dependence of CALB/Novozyme®435 is very much determined by the 
conditions studied. There are reports stating that CALB denature already at 40ºC in aqueous 
solutions, whereas when immobilised and kept dry it can withstand temperatures of beyond 
100ºC for an extended period of time. When used in an industrial application, the optimum 
temperature is a balance between productivity and stability of the enzyme. Novozym®435, 
has been suggested for the production of a number of different speciality chemicals as can be 











Emollient ester C14 acid + C14 alcohol 60 7000 21, 22, 23 
Wax ester C16 acid + C16 alcohol 65 10.000 24 
Ester Decanoic acid + propane-2-ol 60 600 25 
Biodiesel TG + methanol 30 50 26 
Sugar ester Myristic acid + glucose 60 20 27 
Polymer e-Caprolactone ring 
opening polymerisation 
70 130 28 
Acrylation Acrylic acid + octanol 50 100 29 
t-acrylation Ethyl acrylate + octanol 50 700 30 
Acyl glycerols Sunflower oil + glycerol 40 3000 31 
Ceramides 
 
2-hydroxy-propyl amine + 
octadeca-9,12-cis-cisdienoic acid 
65 >200 32 
 
Table 6  
Reaction rates and reaction conditions for some suggested applications 
of Novozym®435 for the synthesis of speciality chemicals 
 
The ideal temperature will probably be as low as 30ºC or lower for processes involving 
substrates that have a clear adverse effect on the enzyme, as methanol in biodiesel production. 
For processes that only involve hydrophobic reactants, as is the case in the synthesis of wax 
esters, the process can probably be run at 70-80ºC without severe inactivation of the enzyme, 
especially if the system is kept relatively dry (particularly avoiding the formation of a separate 
water phase). 92 
Lipase B from Candida Antarctica (CALB) has been widely used as a catalyst in kinetic 
resolutions. The enantioselective performance of enzymes is expressed as the enantiomeric 
ratio E, which is a measure for the selectivity of a enzyme for one of the enantiomers of a 
substrate. Michaelis-Menten kinetics equations developed for enzyme catalyzed reactions. 
relate the conversion of the (racemic) substrate, the enantiomeric excess, and the 
enantiomeric ratio (E-value). 93 
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Suppose that the substrate consists of enantiomers A and B which are, respectively,  the fast 
and slow reacting enantiomers that compete for the same site the enzyme. Assuming the 
enzyme catalyzed reaction follows a simple three-step kinetic mechanism (Fig.1), the reaction 
is virtually irreversible, and there is no product inhibition, the enantiomeric ratio is given in 
equation reported in figure 12. 
 
A + enzyme



















Figure 12  
 
 
VA, KA and VB, KB denote maximal velocities and Michaelis constants of the fast- and slow-
reacting enantiomers, respectively. Equation in scheme 12 shows that the discrimination 
between two competing enantiomers (A and B) by enzymes is equal to the E-value. In 
particular, high enantiomeric ratios, E, have been obtained with secondary alcohols1–4.  
On this basis, it is important to understand what structural features in the substrate controls 
the enantiomeric discrimination of this enzyme. 
Crystal structure of CALB shows that its active site is buried in the core of the enzyme, and 
the enzyme contains a catalytic triad (Ser105–His224–Asp187), an oxyanion hole (Thr40 and 
Gln106) that stabilizes the transition state as well as a cavity called the stereospecificity 
pocket.94 The bottom of the pocket is defined by Trp104. Binding site of CALB has a funnel-
like shape and during a typical reaction, an ester is bound in the acyl- and alcohol-binding 
sites (Fig. 13). CALB does not seem to have a structural element that covers the active site, 





Figure 13  
Transition state analog crystal structure of CALB and its binding site. 
 
The alcohol-binding part, which contains the stereospecificity pocket, gives CALB high 
substrate selectivity towards secondary alcohols.93-97 
It is important to realize that the enantiomeric ratio reflects the ratio of reactivity between 
the fast and slow reacting enantiomer. Therefore, it is not straightforward to explain the 
reason for a steric effect on E on the basis of molecular modelling unless both enantiomers are 
taken into account.  
This structural  feature implies that CALB does not show interfacial activation which has 
been taken as the most characteristic property of lipases.98,99   
Most researchers attributed lipase enantioselectivity to the differences of productive binding 












Studies conducted by Roticci et al.100 were oriented about the enantioselectivity of Candida 
antarctica lipase B (CALB) towards acyclic sec-alcohols in order to delineate the substrate 




Schematic representation of CALB’s productive binding modes for alcohol enantiomers. 
Position with M sostituent in stereospecificity pocket is called “Docking mode I”, while 
when L sostituent is in stereospecificity pocket, the position is called “Docking mode II”. 
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High enantiomeric ratios (E) were found for long chain alcohols with an M substituent 
smaller than n-propyl and L substituent bigger than ethyl. Further extension of the M group 
entailed a drop in activity and enantioselectivity. 
Thus, they concluded that the enzyme provides space enough to accommodate an M 
substituent smaller than an n-propyl group. In that work, all substrates tested with CALB 
followed the empirical rule proposed by Kazlauskas et al.4 for the prediction of the fast 
reacting enantiomer. When the M group was kept fixed, E increased while increasing the size 
of the large (L) substituent  (Table 7).  
 
 Substrate Enantiomeric  
ratio 
























Table 7  
Enantioselectivity of CALB towards short chain alcohols. 
 
A drastic difference in selectivity between 2-butanol (c) and 2-pentanol (d) or 3-methyl-2-
butanol (e) was also noted even though their large groups differ only by one methyl.  
The dramatic increase in enantioselectivity for 2-pentanol (E=390) compared to 2-butanol 
(E=9) could be rationalised with the help of molecular modelling. R enantiomers bind with 
the M substituent in the stereospecificity pocket. The pocket provides enough space to 
accommodate each M substituent in docking mode I. In order to be catalysed, S enantiomers 
have to place the large substituent in the stereospecificity pocket. In the latter docking mode 
II, the pocket provides room enough to fit the L group of (S)-2-butanol. Modes I and II can 
thus operate simultaneously on the R and S enantiomers respectively, resulting in a low E.  
On the other hand, the n-propyl substituent of (S)-2-pentanol can hardly fit in the pocket 








































2.1 Introduction to macrolactones 
Macrolactones are macrocyclic lactones with more of 12 atoms in the ring. Some 
macrolactones known also as macrolides, are generally acknowledged to be one of the safest 
class of antimicrobial agents used extensively in the treatment of upper respiratory tract and 
skin structure infections particularly for children and penicillin-allergic patients.  
The chemistry of macrocyclic compounds originated in 1926 when Ruzicka101 elucidated the 








        
Civetone (1)  
 
O
      
Muscone(2)  
Figure 15 
Before this time it was believed on the basis of Baeyer’s strain theory 102 that large-ring 
compounds would be too unstable to exist because the internal bond angles in large planar 
rings do not have tetrahedral geometry. In fact, large rings are able to adopt non-planar 
conformations and they are flexible and almost strain free. 
In 1927 Kerschbaum isolated the first macrocyclic lactones, exaltolide (3) and ambrettolide 













          
Ambrettolide (4)  
Figure 16 
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The discovery of these vegetable musk oils aroused interest in finding synthesis routes to 
these and related macrolides owing to their commercial importance in the fragrance 
industry.104,105 The great breakthrough in macrolide chemistry came in 1950 when 













The growing interest in macrolides chemistry can be understood taking a look at the 
diversity of the structures and physiological effects of macrolides. Natural products 
containing a macrolactone framework are found in plants, insects, and bacteria and they may 
be of terrestrial or marine origin. The useful properties of macrolides range from perfumery 
to biological and medicinal activity. The new findings in the field of antitumour active and 
antibiotic macrolides, together with pheromones and plant growth regulators with 
macrolactone framework, are an inspiration to chemists to study macrolides. 
 
2.1.1 Macrolactones of pharmaceutical interest 
Macrolide antibiotics play a therapeutically important role. They are regarded as among the 
safest of antibiotics and they have successfully been used to treat infections caused by gram-
positive organisms and certain gram-negative and anaerobic bacteria.108 The wide variety of 
macrolide structures in nature can be appreciated just by looking at some examples of 
different types of macrolide antibiotics (Fig.17).  
The most important macrolide used as antibiotics include erythromycin (11), azithroymcin 
(12) and clarithromycin (13). The prototypical macrolide, erythromycin, became available in 
the 1950s. Natural macrolide antibiotics can be classified according to the size of the aglycone 
ring. and are classed according to the number of lactone ring components; the 12-membered, 
















































































































Erythromycin, oleandomycin and troleandomycin belong to  the 14-membered group. 
Spiramycin, josamycin and tylosin are the only 16-member macrolides in clinical use. None of 
the 12-member macrolides are used clinically. Azithromycin and clarithromycin are semi-
synthetic derivatives of erythromycin that are characterized by increased tissue penetration 
and improved gastrointestinal tolerance.  
Recent findings in the field of macrolides include the first isolated mycobacterial toxins, 
mycolactone A and its isomer B (14), containing a 12-membered lactone ring.111 
Mycolactones are shown to be directly responsible for the necrosis and immunosuppression 








          
 Mycolactone B (14)  
 
Most of the  pharmacologically active macrolides have highly substituted structures as can be 
seen from the few examples above. However, complexity of the structure is not essential for 
antibiotic activity. Relatively simple macrolides such as macrolide A26771B (15)113 and 
patulolides A (16)114, B (17)115, and C (18)116 are antimicrobial compounds. Interestingly 


















2.1.2 Macrolactones as chemical signals 
The chemical communication among several organisms is assured by the emission of chemical 
substances acting as signals (semiochemicals). The signals are chemical compounds capable of 
transmitting information to individuals of the same species or different species. This type of 
communication is very favorable in terms of energy because even small amounts of substance 
can cause a behavioral response that can last hours or even days. The duration depends on the 
molecular composition of the substance emitted, in turn closely linked to the type of message 
to be transmitted. Some messages, because they have to reach the maximum number of 
individuals and spread rapidly, such as warning signs, have very low molecular weight and 
therefore high volatility. Instead, signals that must persist for a longer time in the 
environment, such as signal trace, have a higher molecular weight and lower volatility.  
Depending on the type of interaction, the chemical signals are divided into: 
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PHEROMONES: used in intraspecific communication, are secreted outside causing a 
behavioral response in individuals of the same species. They are the basis of structure and 
function of insect societies. They mediate the recognition of kin and of belonging to their 
colony, reproduction, caste determination, behavior of alarm and recruitment. 
 
ALLOMONS: generally mediate interspecific interactions and bring benefit to the emitter 
and the receiver. Belong to this type of signals, any substances secreted by predators (many 
species of vertebrates but also invertebrates and plants) to attract prey. 
 
KAIROMONES: unlike of allomons bring benefit to the recipient and not the emitter.  
 
These chemical stimuli play an important role in the search for food and no predator-prey 
relationship, encouraging such behavior in the prey to escape. Some pheromones, e.g. those of 
the saw-toothed grain beetle, Oryzaephilus surinamensis, and related cucujid species O. mercator, 
Cryptolestes ferrugineus, C.turcicus, and C. pusillus, have rather simple macrolactone structures 
(Figure 15).117-118 These beetles are major pests of cereal and grain on a world wide scale and 
some of these pheromones have been patented as attractants for insect traps119 in order to be 












O19 20 21 22 23  
Figure 18 
Examples of macrolide pheromones 
 
Pheromones released by the stink bug Piezodorus hybneri  are characterized by a mixture of 







15-hexadecanolide (24)  
 
Compounds with allomones role were recently isolated from marine organisms more of other 
animal’s kingdom. These creatures are a particularly rich source of bioactive compounds 
because natural selection has forced them to develop an elaborate chemical arsenal in order to 
ensure their survival.121 Marine organisms generally more studied are sponges, algae, 
jellyfish, corals, echinoderms, tunicates, bryozoans and molluscs. In fact, these invertebrates, 
often brightly colored, constitute easy preys. However, during evolution, many of them have 
developed viable defense strategies, producing, or assimilated from the diet, unusual and 
interesting chemicals studied by the scientific community increasingly concerned with the 
search for new active ingredients. The origin of these compounds has been the subject of 
many studies. In many cases it was shown that they are byosyntetized de novo; in others, these 
substances are taken from the diet, stored in the digestive gland and, when appropriate, used 
for defense. The defense mechanism used to deter predators involves the secretions or 
mucous concentrated in peripheral tissues. For example, molluscs such as Aplysiae are devoid 
of physical protection: during evolution, in fact, have reduced or gradually lost their shell 
because this will restrict the movement and have developed more sophisticated alternative 
defensive strategies based on the use of toxic chemicals or repellents (allomones defense). 
Aplyolides (Fig. 19) are macrolactones isolated from the mantle of Aplysia depilans.122 
Aplyolide A (25) derives from cyclization 15-(S)-hydroxyhexadeca-4(Z), 7(Z), 10(Z), 13(Z)-
tetraenoic acid. The lactones B (26) and D (27), result from cyclization at the C-15 or C-16 of 
15(S), 16(S)-dihydroxyoctadeca-9(Z), 12(Z)-dienoic acid and differ from lactones C (28) and E 






Other examples of macrolactones acting allomones are the class of azamacrolides123 (30, 31, 











n=1, R=Me Norepilachnene (31)




A novel class of antiviral and cytotoxic 24-membered lactones have been isolated from the 
culture broth of an apparently taxonomically unclassifiable marine bacterium.124 Macrolactine 














     
Aplyolide B (26)
       
Aplyolide C (28)
        
Aplyolide E (29)
        
Aplyolide D (27)















A series of cytotoxic macrolides, named amphidinolides (34, 35), were isolated from symbiotic 
marine dinoflagellates of the genus Amphidinium which were separated from inside cells of 






















2.1.3 Macrolactones (and other macrocycles) in fragrance industry 
The musks are of central importance for the fragrance industry. They form the bottom note of 
a perfume composition, i. e. the musky undertone stays the longest on the skin or on the 
fabric. The musk odour is difficult to describe, it is often called warm, sweet, powdery, animal, 
etc., it is longlasting, tenacious, and substantive. The use of musks goes back to antiquity, and 
is itself a chapter of human cultural history. 126 
The chemistry of the natural musk odorants started with the discovery of the macrocyclic 
musks, ketones and lactones, during the first half of last century, when their isolation from 
animal and plant sources and subsequent structure elucidation took place. 
Muscone, civetone, and Exaltone ® are the main odorous principles from the animal 
kingdom, whereas the lactones Exaltolide ®, and (Z)-∆7-ambrettolide have been isolated from 
plants (Fig.21). 127 
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The discovery of these vegetable musk oils aroused interest in finding synthesis routes to 
these and related macrolides owing to their commercial importance in the fragrance industry. 
However, in past, musky molecules were characterized by a class of nitro- compounds 
discovered by serendipity during the search for new explosives a hundred years ago,128,129 
when the structure of the above natural musks was not yet known, and their price was 
exorbitant. Musk xylol, Musk ketone, Musk Tibetene, Musk Ambrette, and Moskene ® are 








        
Musk ketone (38)
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Musk ambrette (40)
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It is a fascinating coincidence, that these penta- and hexasubstituted polynitro benzene 
derivatives display a musky odour, with an ambery, sweet vanilla, powdery character, and a 
touch of a highly esteemed animal tonality. Because of these odour characteristics, and their 
very favourable price, especially compared to the natural and later synthetic macrocyclic 
musks, the nitro musks became high-volume industrial chemicals. During the 1980s their use 
began to decline. The reason is partly toxicological,130, 131 partly practical, but mainly far the 
introduction of another class of high-performing musks to the market. 132 
This new class of synthetic musks consists of polycyclic, aromatic compounds. Phantolide® 
(42),133 Celestolide® (43),134 Traseolide® (44),135 Fixolide® (45) or Tonalide®,136 and 
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Galaxolide® (46)137 are the main representatives, the last two being the most important 
today.  
O
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Their chemistry is text-book aromatic  chemistry, their odours are musky with fruity and woody 
effects, and an animal undertone. The polycyclic musks are today in the same price class as the 
nitro musks or even cheaper, i.e. US $120-150 per kg, and several thousands of tons are 
manufactured per year. However, because of their low biodegradability, and their tendency to 
bioaccumulate, they are causing some concern today. 138-140 
The chemistry of the nitro musks can be considered today as a closed chapter, and that of the 
nitro-free aromatic, polycyclic musks is also approaching an end.  
On the other hand, in recent years, advances in the synthesis of macrocyclic compounds have 
driven cost down to competitive levels and  popularity of macrocyclic musks amongst 
perfumers is growing steadly as their price/performance ratio increases favourably. Any 
synthesis of both macrocyclic ketones or lactones has its key step in the formation of the large 
ring (14-17 membered in the case of macrocyclic musks). The first approaches as well as the 
first industrial syntheses all used the technique of macrocyclization. In connection with the 
synthesis of antibiotic macrolides new macrocyclization strategies have been developed 








2.2 Chemical synthesis of macrolactones 
The key step in macrolactones synthesis is the formation of the macrocyclic ring. 
Macrolactones are prepared using several strategies and intramolecular cyclization of 
bifuntional acyclic molecules is the most frequently employed.   
Intramolecular ring closure of open, long chain precursors is disfavoured entropically, owing 
to the loss of entropy associated with the formation of a usually more rigid ring structure.141 
Illuminati and Mandolini, who have studied 
carefully factors controlling cyclization of omega-
bromo acid, Br-(CH2)n-2CO2H, have reported that 
macrolactonization is dependent on activation 
energy, related to energy developed by the tension 
ring in training and in terms of entropy on the 
probability of meeting the ends of the molecule as 
required for the reaction. 142 
Generally, the enthalpic factor prevails entropy in 
the formation of lactones consisting of medium 
sized rings because of strain energy in the ring 
being formed; on the contrary, in reactions of 
intranolecular lactone ring of large scale, the 
entropy factor increases, while the enthalpy 
decreases until the strain of cycle is minimal. These 
results are shown in the profile of reactivity (Fig.24) 
whereby the cyclization to macrolactones molecules 
consisting of 8-11 carbon atoms are more difficult 
because of the combination of both factors enthalpic and entropic. 
The main problem arising in the macrolactonization is the competition between intra- and 










+    ....
"olide" "diolide"  
 
The principal method for favoring intramolecular reactions in this competition is to use a 





Reactivity plot for the formation of lactones in  
99% Me2SO at 50°C from the parent  
ω-bromoalkanoate ions. In the right-hand  
scale the effective molarities (EM) are reported. 
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To assess the dominance between intra- and intermolecular reactions, the effective molarity 
(EM) is used as a fundamental quantity in cyclization reactions. 145 EM is expressed by the 
equation EM = kintra/kinter where EM represents the reactant concentration at which 
cyclization (kintra) and polymerization (k-inter) occur at the same rate. In practice this means 
that when the cyclization is done batch-wise, ring closure predominates over polymerization 
if the initial concentration of the substrate is lower than EM. The effective molarity depends 
on both the enthalpy of activation ∆H‡ and the entropy of activation ∆S‡. The enthalpy term 
decreases when the chain length of the bifunctional substrate increases, but the relationship 
between enthalpy of activation and the strain energy of the ring being formed is far from 
simple. It has been observed that the strain energies of transition states are lower than the 
strain energies of the formed lactones, which means that only a fraction of the product ring 
strain shows up in the transition state The entropy effects of the cyclization are more 
straightforward. As long ago as 1935, Ruzicka proposed that the probability of end-to-end 
reactions in a bifunctional linear precursor decreases as the chain length increases. This 
postulate was later fully confirmed with entropy of activation data for cyclization reactions  
Because very dilute solutions are impractical in synthetic work, the high dilution is generally 
obtained by the influxion procedure, where the reactant or reactants are slowly introduced 
into the reaction medium over a long time. The optimal situation is that the starting material 
flows into the reaction flask at the same rate as the cyclized product is formed; that is to say, 
high dilution does not simply mean the use of a large volume of solvent but rather the 
establishment of a stationary concentration of substrates. Flow equilibrium of substrate influx 
and product outcome may also be achieved with relatively small solvent volumes. In the 
influxion procedure the rate of feed is a critical parameter and should be smaller than 
EM·kintra. The rate of feed controls the duration of the process and so describes its efficiency. 
Even though physicochemical studies have been made on the effective molarity of cyclization 
reactions, the high dilution principle is in general used empirically. 
Several extensive reviews on methods of macrolactonization in the total synthesis of natural 
products.146 
Generally, direct cyclization of a long chain hydroxyl acid cannot be easily obtained and 
activation of one or both functional groups is needed. 
 
2.2.1 Macrolides by ring closure trough acid activation 
The most famous reaction involve the “double activation” method described in 1974 by Corey 
and Nicolaou.147 The mechanism involves the initial formation of a 2-pyridine thioester of the 
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ω-hydroxy acid via a Mukaiyama oxidation-reduction condensation with PySSPy and 
triphenylphosphine.148 Internal proton transfer then affords an intermediate in which both the 
carbonyl and the hydroxyl group have been activated, leading to the “electrostatically driven” 

























This “double activation” has been confirmed, and a mechanism involving ketene formation 
was ruled out by deuterium labeling and kinetic studies.149,150 
The “classical” Corey-Nicolaou method has been used in a large number of total syntheses 













         
Scheme 4 
 
A substancial increase in the rate of cyclization in the presence of metal ions (Ag, Hg, Cu) has 
been reported. 152 The activating effect of the thiol ester is also utilized in the Masamune153 
macrolactonization reaction. A rapid lactonization occurs when S-t-butyl thiolester of 
hydroxy acid reacts with an electrophilic Hg(II)-compound such as mercuric trifluoroacetate. 
The mechanism of the Masamune method (Scheme 5) has not been fully clarified and two 














a b  
Scheme 5 
In 1976 Mukaiyama154 showed a method involving the hydroxy acid activation with 1-
methyl-2- chloropyridinium iodide. The mechanism of this reaction is fairly similar to that of 
the Corey double activation method. The mechanism involves (Scheme 6) chloride 
substitution by the carboxylate ion to give a highly activated acyloxypyridinium species 




















Syntheses using this methodology of various macrolactones have also been described. Among 
them there is the synthesis of gloeosporone (48)155, in which the 14-membered macrolactone 
is formed (Scheme 7), various aggregation pheromones 156, and nine membered 


















Another very practical method for macrolactonization was described by E. P. Boden and G. E. 
Keck159, who used DCC, DMAP, and DMAP•HCl to inhibit the formation of N-acylurea in 
the Steglich esterification.160 Recently, was developed an efficient macrolactonization protocol 






























2.2.2 Ring closure trough the formation of anhydride intermediate  
A very common way to activate the carboxyl group of a long chain hydroxy acid is to convert 
it to a mixed anhydride. The anhydride reacts with the hydroxy group under base-catalysed 
reaction conditions, leading to a lactonized product. One of the most commonly used mixed 
anhydride methods is the Yamaguchi lactonization. 162 It has been applied for the synthesis of 
more than 200 naturally occurring macrolides. This method has been utilized with success, 













Patulolides C (18)  
Figure 25 
 
The Yamaguchi reaction consists of two steps: the formation of the mixed anhydride and the 






























The mixed anhydride is prepared to accelerate the reaction and overcome the unfavourable 
entropy factors leading to the formation of polymeric products. 2,4,6-Trichlorobenzoyl 
chloride is used to prepare the mixed anhydride, for two reasons: it forms a good leaving 
group and it is sterically hindered towards nucleophilic attack. The alcoholysis reaction is 
catalysed by 4-dimethylaminopyridine (DMAP), which is highly active in acyl transfer 
reactions. In the preparation of large-ring lactones the alcoholysis step of the reaction is done 
under high dilution conditions, usually in refluxing benzene or toluene, and the amount of 
DMAP is from three to six equivalents. In a modification of the Yamaguchi lactonization 
reaction, 2,4-dichlorobenzoyl chloride has been used instead of 2,4,6-trichlorobenzoyl 
chloride to prepare the mixed anhydride.164  
The main drawback of the Yamaguchi procedure is the use of the highly basic DMAP and 
high temperature. These factors sometimes lead to undesireable side reactions such as α/β to 
β/γ isomerization of conjugated double bonds, epimerization of sensitive chiral centers165, and 
Z/E isomerization of conjugated double bonds.166,167 The latter problem is usually solved by 
performing the macrolactonization on the ynoic seco-acid 50 and then reducing the triple 






















2.2.3 Macrolides by ring closure trough alcohol activation  
Macrolactonization can further be achieved by activating the hydroxy group of the hydroxy 
acid. This methodology, presented in 1976 by Mitsunobu, is based on the activation of the 
seco-acid alcohol using diethyl azodicarboxylate (DEAD) and triphenylphosphine.169,170 
Initially, diolides were usually obtained as the major products for medium ring lactones,171,172 
and the Mitsunobu reaction has long been considered as a selective method to obtain diolides. 
A modification was introduced by Steglich in 1991 during the synthesis of combrestatin 
analogues.173 Using the classical Mitsunobu protocol, the diolide was obtained as the major 
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product (diolide 40%, macrolactone 2%), but with slow addition of the seco-acid to DEAD-
triphenylphosphine, the macrolactone was the major product (macrolactone 59% yield, diolide 


































In the reaction mechanism, the key intermediate is an alkoxyphosphonium salt produced in 
situ, and the macrolactonization proceeds via an intramolecular SN2 reaction and with 
inversion of the alcohol configuration. This reaction has been used in a number of 11- to 16- 
membered macrolactones, 174 for example in the total syntheses of natural products such as 




















2.2.4 Ring closure by C–C and C=C bond formation 
In addition to macrolactonization reactions, also several other methods have been used for the 
preparation of macrocyclic lactones through ring closure. Many reactions involving C–C or 
C=C bond formation can be utilized intramolecularly to afford macrolides. 175,176  
Metal-catalysed coupling reactions, such as oxidative coupling of ω,ω’- diacetylenic esters 
with Cu(OAc)2, coupling of allylic dibromides with nickel carbonyl, intramolecular palladium 
catalysed coupling of stabilized anions with allylic acetates, and intramolecular palladium 
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catalysed coupling of acid chlorides and ω-stannylalkenoates in the presence of CO, have been 
utilized to prepare macrolides of different size. 177,178 
Also other intramolecular C–C bond formation reactions such as Dieckmann condensation 
and Diels–Alder reaction have been applied in the preparation of macrolides. 175 Ring closure 
by Diels–Alder reaction is particularly useful in the construction of cytochalasans and their 
skeleton structures. 176 
For macrolide ring closure by C=C bond formation, intramolecular Wittig like reactions are 
useful and generally give good yields.179 
A relatively new but very efficient route to macrolides through C=C bond formation is the 
ruthenium carbene (55) catalysed reaction of 1,ω-dienes by ring-closing metathesis (RCM) 

















The RCM method for macrolide ring closure has been utilized in several synthesis of natural 
products. 181 An application of RCM is the syntheses of natural odoriferous macrolides such us 
Exaltolide,182 a valuable musk-odored olfactory ingredient of Archangelica officinalis (Scheme 
14). Acylation of 1-hex-5-enol with 10-undecenoyl chloride with 5-hexenoic acid gave dienes 
(56). Slow addition of a CH2Cl2 solution of these compounds to a solution of the Grubbs 
carbene (4 mol %) in the same solvent at ambient temperature led to the corresponding 16-
membered lactones (57) (Z:E ) in excellent yields. Hydrogenation of these compounds 





















Olefin metathesis is now an established technique for ring-closure of macrocycles, and 
recently new catalytic systems have emerged to give new impetus to this field. 183, 184 By a 
ring-closing methathesis employing the Grubbs catalyst (55), diene (59) was transformed in 
68% yield to (+)-(12R)-12-methyl-13- tridecanolide (60);185 the stereogenic centre was 
created via Oppolzer's bornane 10,2-sultame (58) (Scheme 15). While the enantiomers of 
muscone smell very similar, the enantiomers of 12-methyl-13-tridecanolide, which is a 
natural constituent of angelica root oil (Archangelica officinalis), differ significantly in their 
odour characteristics: (+)-(12R)-(60) possesses a musk note with a sandalwood tonality, while (-)-
























2.2.5 Other methodologies  
Other methodology used in macrolactones preparation are below decribed. 
Examples of ring expansion procedures include the Baeyer-Villiger oxidation of macrocyclic 
ketones186-188 and the Fe2+ ion promoted fragmentation of alkoxy hydroperoxides. Except for 
symmetrical ketones, the Baeyer-Villiger oxidation is not generally applicable for 
macrolactones synthesis because of the formation of isomers and the relatively harsh 
conditions that are required (peracids). Althought a higly region- and stereoselective 
synthesis of recifeiolide was achieved by the fragmentation of an alkoxy hydroperoxide 
precursor, this method has not been tested on molecules with sensitive functionale groups. 
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For the musk specialities this route became important when cyclododecanone (43) came to 
the market, at a reasonable price, as one of the downstream products of the butadiene 
oligomerization in the early sixties. A few examples shall demonstrate here the utility of 
cyclododecanone (61) as a starting material. 61 can be transformed in two steps into the 
bicyclic enolether 62, which upon treatment with hydrogen peroxide (70%) yields the 
hydroperoxide 63. The labile 63 then undergoes a fragmentation reaction (64) to a mixture of 
exaltolide® (3), and the dehydro-exaltolides (Scheme 16).189-191 This fragmentation has been 
studied in more detail under iron-copper catalysis. 192 The mixture of the dehydro-exaltolides 



















       3 
exaltolide








The discovery of vegetable musk oils aroused interest in finding synthesis routes to these and 
related macrolides owing to their commercial importance in the fragrance industry. 
Among methodologies used to obtain odour compounds, the Story´s synthesis,194-196 is one of 
most important and it´s the corrent industrial process to prepare exaltolide (3) by 

























Despite the obvious hazardous nature of the intermediates, this approach presents a very 
economical approach to macrocyclic lactones. 197  
Another industrial route for the large-scale synthesis of C15 and C16-lactones involves a 
polymerisation-depolymerization process.198,199 Hydroxyacid is initially dehydrated to give a 
polyester. Then, in the presence of a catalyst, heating under vacuum, depolymerization gives 
macrocyclic lactone (Scheme 18). This method was patented by Carothers at DuPont in 



































































The ester forming ability of lipases has been used for regiospecific interesterification of 
tryglicerides201 and preparative resolution of chiral acids and alcohols via enantiospecific 
esterifications202. Of course, the ability of lipases in enzyme catalyzed esterification and 
transesterification has prompted some investigations on their use for intramolecular 
reactions. 203 
First applications of lipase for the catalysis of intraesterification of hydroxyacids or 
hydroxyesters dates back in the 80s.204-207  In 1984, Gatfield204 was the first to observe that a 
lipase (Mucor miehei) is able to catalyze the intramolecular esterification of 15-
hydroxypentadecanoic acid to pentadecanolide. This observation was confirmed by Yamada et 
al. in 1987.205 They found that only Pseudomonas sp. and Porcine pancreatic lipases catalyze 
efficiently  the lactonization of methyl 16-hydroxyhexadecanoate (71) producing, with high 











Lipase used Yield of 
lactone (%) 
 Lipase used Yield of 
lactone (%) 
Pseudomonas sp. 78  Rhizopus delmer 0 
Porcine pancreas 73  Candida cylindracea 0 
Rhizopus japonicus 2  Wheat germ 0 
 
Table 7 
Efficiency of several lipases in lactone synthesis from methyl 16-hydroxy 
hexadecanoate (1mM in dry benzene, 500mg of each lipase, 40°C, 72h). 
 
They reported that lactonization was also dependent on the length of the ω-hydroxyester. In 
fact, the cyclic dimer formation decreases and the monolactone yield increases with increasing 
chain length of ω-hydroxyesters, going from C13-C16 (Table 8).   
 
HO-(CH2)n-COOCH3 Yield of lactone (%) 
n=12 38 (25)* 
n=13 64 
n=14 78 
n=15 80 (3)* 
* cyclic dimer yield. 
Table 8 
Substrate specificity of lipase P in lactonization reaction 
(1mM in dry benzene, 3g of lipase, 40°C, 72h). 
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Yamada also has investigated the effect of solvents on the lactonization, observing that best 
results are obtained using non polar solvents. It was observed that initial reaction rate was 
different for various solvents although the lactone yield is often the same. In fact, the initial 
rate for lactonization of methyl hydroxyhexanoate in n-heptane was almost 7-fold higher 
than rate in benzene, but the same amount of lactone was obtained in both cases (table 9).   
 
Solvent used Reaction rate 
(nmoles mg-1 min-1) 
Yield of 
lactone (%) 





n-heptane 0,67 78 Benzene 0,09 78 
n-hexane 0,65 80 Dimethylsulfoxide 0 0 
cyclohexane 0,59 79 Ethyl acetate 0 0 
Table 9 
Effect of solvent on the reaction rate and the yield in lipase P catalyzed lactonization  
(1mM methyl 16-hydroxyhexadecanoate). 
 
Similarly, Sih et al.,206 exploring the relationship of substrate structure of different ω-
hydroxyacids, found that product profile varies with the length of carbon chain. Furthermore 
a complex of di- tri, tetra and penta-lactones were formed in different ratios, depending of 
lipase used. For examples, the lipases of Pseudomonas sp. and Porcine pancreas produce di- and 
trilactones while the lipase of Candida cylindracea and Mucor meihei gave mostly tri- and 










Lipase + di  + tri   + tetra   + penta
 
Scheme 20 
n Lipase Mono Di Tri Tetra Penta 
8 Pseudomonas sp. AK 0 53 16 4 * 
 Pseudomonas sp. K-10 0 33 14 15 7 
 Porcine pancreas 0 57 20 6 2 
 Candida cylindracea 0 4 26 11 * 
 Mucor meihei 0 2 20 15 * 
       
12 Pseudomonas sp. AK 66 26 *   
 Pseudomonas sp. K-10 62 30 *   
 Porcine pancreas 46 21 12   
 Candida cylindracea 19 15 9   
 Mucor meihei 3 43 15   
Table 10 
Lipase catalyzed lactonization of ω-hydroxyacids 
 
O’Hagan et al. reported that 16-hydroxyhaxadecanoic acid incubated (65°C, 48 h) with porcine 
pancreatic lipase in hexane furnished 34-membered diolide in 25 % yield. 207 
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A enzymatic methodology for the construction of macrocyclic lactones via direct 


















O O  
Scheme 21 
 
Experiments on specificity of lipase were subsequently conducted by Robinson et al.  in fact in 
a screening of 33 esterases and lipases.209 They showed that only microbial lipases from 
Pseudomonas fluorescens and Candida antarctica were able to catalyze efficiently the intra-
esterification, especially in methylene chloride, chloroform and benzene.  
Antczak et al.2010 found that from among seven tested lipase preparations, Lipozyme IM20 and 
Mucor javanicus L46 and Mucor racemosus L45 show ability to catalyze lactonization of ω-
hydroxyacids (C15 and C16) to macrocyclic lactones (pentadecanolide and hexadecanolide), 
with yields of monolactones range from a few percent to over 30%, depending on the 
substrate concentration, enzyme concentration, solvent type, time, temperature of system 
reaction, pH of the essential water layer and the addition of aprotic solvents. 
Hydroxyacids or hydroxyesters containing a secondary alcohol moiety are very interesting 
substrate because these chiral compounds allow an investigation on the asymmetric nature of 
the lipase catalyzed lactonization, however they have been scarcely used as substrate. Two 
investigations on lipase catalyzed lactonization of short chain (C8-C13) (ω-1)-hydroxyacids 
showed that mainly di- and trilactones were obtained.211 The reaction conducted using 
racemic methyl 10-hydroxyundecaoate yielded an optically pure diolide. The analysis of its 
optical purity allowed the conclusion that lipase P reacted preferencially with (R)- isomer of 
the starting hydroxyacid methyl ester. 205 This result is consistent with the empirical rule of 
Kazlaukas on R-preference of lipase towards secondary alcohols.94 
Studies on substrate with unsaturations along carbon chain, were conducted by research’s 
group of Ohta examining the effect of structure of the substrate with fixed ring size.212 They 
found that in lipase-catalyzed macrolactonization the presence of a double bond in the chain 





COO2Me Lipase Pseudomonas sp.






R1 R2 Conversion % Yield % % e.e. Configuration 
71    C6H13 CH2CH2 91 14 >99 R 
72    C6H13 CH=CH (E) 87 18 >99 R 
73    C6H13 CH=CH (Z) 70 20 98 R 
 
Table 11 
Lactonization of hydroxy esters with Pseudomonas sp. lipase. 
 
An important factor in enzymatic macrolactonization is the product concentration. Robinson 
et al. have demonstrated that the presence of hexadecanolide product is inhibitory to the 
lactonization of C16 ω-hydroxy acids.209 They also demonstrated that the addition of water 
decreased the rate and amount of lactone formation from C16 ω-hydroxy acids. So the water 
content can be considered an important parameter for these catalyzed reactions. Efforts were 
also directed to improve catalytic efficiency by changing properly reaction environment. With 
this aim, Rees et. al.213 screened some microbial lipases from Chromobacterium viscosum, 
Candida cylindracea, Pseudomonas and lipoprotein lipase ex Microbial, for lactonization activity 
towards 16-hydroxyhexadecanoic acid in a variety of different water / oil microemulsion 
systems. With the exception of Candida cylindracea, all the lipases exhibited lactonization 
activity although they were inherently more active in microemulsion systems based on the 
anionic surfactant sodium bis (2-ethylhexyl) sulphosuccinate (AOT) than in those based on 
the cationic surfactant cetyltrimethylammonium bromide (CTAB). Lactone yields were 
typically 50-60% and were markedly better than those reported using microemulsions in 
combination with chemical catalysts (Table 12).  
 % Yield of 
hexadecanolide in AOT 
incubations 
 % Yield of 
hexadecanolide in CTAB 
incubations 
Lipase R=10 R=40  R=10 R=40 
Chromobacterium viscosum 55 58  51 52 
Pseudomonas sp. 57 50  58 56 
Microbial 54 49  54 49 
Candida cylindracea 0 0  0 0 
 
Table 12 
Hexadecanolide synthesis by lipase in w/o microemulsions based on AOT/n-heptane and CTAB/1:1 
chloroform/n-heptane. R= measure of water content in microemulsion.  Incubation temperature: 40°C. 
 
Although direct lipase macrolactonization appeared an appealing methodology in organic 
synthesis only rare applications can be found in literature.   
One of the first application of enzymatic lactonization to a synthetic process was carried out 
by Mandapur et al.; 214 they developed in 1993 a novel synthetic strategy to obtain (3Z, 6Z)-
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dodecanolide (74), a pheromone producted by Cucujid beetles. At final step, there was an ester 
with an hydroxy group at a suitable position to lactonize (scheme 22). Although in enzymatic 
lactonization of hydroxyesters with short length chain diolide predominates, reducing the 
yield of desired macrolide, in this case Porcine pancreatic lipase was used in benzene to provide 









Other synthetic applications were directed to the synthesis of Ferrulactone II (76). 215,216 
Chattopadhyay et al. found that among a series of lipase, only Porcine pancreatic lipase could 












Lipase catalyzed lactonization was used in the final step of the synthesis of the phytotoxic 
lactone herbarumin III (77). Immobilized lipase from Pseudomonas sp. provided the lactone in 









77Scheme 24  
Another study of enzymatic lactonization reported in literature concerns the synthesis of 
lactone 79 from 13(S)-hydroxy-(9Z,11E)-linoleic acid  (coriolic acid-78) carried out by 
Gargouri et al.218 They obtained, in the presence of lipase N-435, a new lactone containing a 
13 carbon ring with 2 unsaturations and 5 carbon lateral chain (Scheme 25). Testing different 
solvents lactonization yield ranged between 11.9% (acetone) and 42.2% (diisopropyl-ether), 
when a 2 mM concentration was used.  Significative enhancement (73.8% yield) were obtained 








10h78 79  
Scheme 25 
 
In this work, the immobilized lipase N-435 from Candida Antarctica was the most adequate 
catalyst offering a high yield of lactonization. The stability and especially the thermostability 
is one of the advantage of this enzyme that catalyze higly enantioselective transformations of 
many chiral alcohols in esterification, transesterification and hydrolysis reactions. 219 In 
previous work, the immobilized lipase from Candida Antarctica (N-435) showed also important 
production of intramolecular monolactone (hexadecanolide). 220 
Lipase catalyzed macrolactonization has been recently used in the synthesis of some 



















































Novozym 435 / THF
MS, 30°C, 90h, (75%)
Novozym 435 / THF









The observation that short chain hydroxyacids give mainly di- and trilactones has been 
applied to the preparation of (R,R)-pyrenophorin (84), an antifungal metabolite from 
Pyrenophora avenae. Lipase catalyzed dimeric lactonization allowed the preparation of a 









 Scheme 27 
 
 The main advantages of using enzymes in organic chemistry are related to their 
favourable unique properties, basically their biodegradability and high chemo-, regio- and 
stereoselectivity resulting in low by-product formation. In particular, lipases hold 
considerable promise in synthetic organic chemistry and have found several practical 
applications in this field. 
However, most applications involve intermolecular esterification while only few attemps on 
intramolecular esterification leading to macrolactones have been described.  The reason for 
the lack of data on the use of this method in macrolactone synthesis is probably due to the 
difficulty of finding suitable conditions for obtaining products with yields competitive with 
conventional synthesis methods.  
 Scope of this PhD work is the development of protocol for the improvement of the 
enzymatic approach to synthetize macrolactones, a class of organic compounds with a wide 
range of natural features that make them attractive for their biological fragrance, 
phytotoxicity, pesticide or pheromone activity. 
  
 
3.2 Improvement of the methodology for enzymatic lactonization   
Although first approaches were reported, applications of enzyme catalysis in lactonization 
reactions are rare and, in most cases with low amounts of lactones to the point of preferring 
the chemical synthesis.216,217 
The difficulty of finding suitable conditions for obtaining yields competitive with 
conventional synthesis methods  led us to develop a protocol for the improvement of this type 
of biocatalyzed synthesis. 
In the course of this investigation we improved the enzymatic methodology by optimizing the 
following parameters: 
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  Lipase type; 
  Solvent; 
  Substrate concentration; 
  System temperature 
  Time reaction 
 
3.2.1  Choice of substrate  
16-Hydroxyexadecanoic methyl ester was used as substrate for the study. We have chosen 
this compound, in order to better compare the results with the experiences reported in the 
literature. Furthermore, the obtained lacton, 16-hexadecanolide (85), is an important 
macrocyclic musk lactone with good stability, good odour characteristics and fixative 
properties to volatile fragrance oils.  
The reaction scheme is shown in the scheme 28.  
The hydroxy ester 71 was easily prepared by Fisher esterification of commercial 16-hydroxy 
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3.2.2 Enzyme choice 
Lactonization activity is not a common feature of lipases, but only a specific characteristic of 
some lipases. Thus we started a screening to evaluate which enzyme is most efficient to 
catalyze lactonization reaction. Initially we applied a general method used by Yamada 205 who 
synthesized hexadecanolide starting from methyl 16-hydroxyhexadecanoate at 1mM and 
40°C. 
In the first instance, we chose lipase from Pseudomonas Cepacea because, as reported in 
literature, it appears to be one of the most efficient in terms of yields of macrolactones, 
although long time (72 hours) are required. Results were not encouraging; in fact yields were 
low and long time was required to obtain significative quantity of lactone.   
Subsequently we extended the investigation to other commercial enzymes, choosing those 
that showed significant enzymatic activity (table 13).  
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Among them, we used some immobilized enzymes because in literature is reported that 
immobilization often improves efficiency of catalytic activity. The efficiency of immobilized 
catalyst was already observed in the utilization of Candida Antarctica (CALB) immobilized on 
acrylic resin (commercially known as Novozym 435 ®).  
High yields of lactone were obtained after few minutes, increasing up a maximum value (79%) 
after 1h. But this good result was the only one in the class of immobilized enzyme tested. In 
fact, with immobilized lipase from Mucor miehei  and  lipase immobilized on Immobead 150 
from Pseudomonas Cepacea  we had small amounts of hexadecanolide similar to that obtained 
with Amano Lipase PS from Burkholderia cepacia (Pseudomonas Cep.); this wasn´t caused by 
less activity of both immobilized enzyme compared to CALB, because long time didn´t afford 
any increase. Probably these enzymes were not specific towards lactonization reaction, in 
according to initial definition that lactonization activity is not a common feature of lipases.  
This aspect was confirmed by using other enzymes, not immobilized, but with higher value of 
activity compared to CALB; in some case no lactonization activity was demonstrated, even for 
long time. Results of test are reported in Table13 and show that CALB was best enzyme for 
our experiments. 
To better confront the specific activity of each enzyme, we decided to set the ratio to 44 U 
(where U= units of enzyme defined as µmol of acid formed in a minute by the enzyme during 









≥ 30.000 U/g 
Lipase Acrylic 
resin from Candida 
Antarctica (CALB) 





≥ 30 U/g 
Lipase immobilized on 
Immobead 150 from 
Pseudomonas Cepacea 




















≥ 50.000 U/g 
15’ n.d. 66 % <5 % 7 % n.d. n.d. n.d. n.d. 
30’ 5 % 69 % 8 % 27 % 15 % n.d. n.d. n.d. 
60’ 13 % 79 % 15 % 53 % 36 % n.d. n.d. n.d. 
120’ 25 % 76 % 22 % 48 % 27 % n.d. n.d. n.d. 
180’ 30 % 74 % 30 %  40 % 23 % <5 % <5 % <5 % 
n.d. = undetectable   
Table 13 
 
According with these evidences, we chose Lipase from Candida Antarctica (CALB) 
immobilized on acrylic resin (commercially known as Novozym 435 ®). 
Regarding the relationship between the amount of enzyme and the amount of hydroxy ester 
substrate, we performed tests that allowed to consider equally effective even low 
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concentrations on efficient lactonization by lipase (Table 14). In fact, reducing amounts of 
CALB, catalytic activity was still efficient in hexanolide production without significative 
variation. This evidence is very important because allows to reduce the amount of catalyst 








Time (h) Yield (%) of 16-
hexadecanolide 
1 mM 0,3 40 6 66 
1 mM 0,7 40 6 65 





3.2.3 Solvent choice 
Different solvents were used in the lipase catalyzed reaction on methyl 16-hydroxy 
hexadecanoate. It is well known that the best choice for enzymes in organic solvents is to use 
"hydrophobic"solvents.   
The criteria for determining hydrophobicity of a solvent are subject to dispute. Most 
important indicators of hydrophobicity are: the parameter of Hidebrand (δ), the dielectric 
constant (Σ), the dipole moment (µ) and the coefficient partition (P).223 The best classification 
proposal was based in logP, where P is the partition coefficient of solvent in a mixture octanol 
/ water. The partition coefficient (P) of a compound is generally described as the ratio of its 
concentration in aqueous and organic phases. To obtain high levels of product is essential to 
use an organic solvent in which organic partition coefficient is high. This implies an efficient 
extraction of the product for the organic phase, which produces a higher conversion. The 
most suitable solvents are those with logP greater than 2. Biocatalysis for synthesis reactions, 
such as esterification are generally considered  possible in solvents which are immiscible in 
water (logP greater than 4).224 Examples of logP of some organic solvents are shown in table 
15. 
 
Log P for common organic solvents 
Dimethyl sulphoxide  -1,3 Chloroform 2,0 
N,N-dimethylformamide -1,0 Toluen 2,5 
Ethanol -0,24 Carbon tetrachloride 3,0 
Tetrahydrofuran 0,49 Cycloexane 3,2 
Ethyl acetate 0,68 Octane 4,5 





However, this classification cannot be applied to all enzymes, because it doesn’t consider 
specific interactions between the enzyme and solvent, which are due to the dielectric constant. 
The decrease in dielectric constant of the solvent, allows increased electrostatic interactions 
between ionizable residues of the enzyme molecule, which may cause a reduction in internal 
flexibility of the protein. Whereas the molecular mobility is essential for catalytic activity of 
the enzyme, reducing its flexibility is usually accompanied by a decrease in activity of enzyme. 
Changing the value of the dielectric constant also alters the value of pKa of ionizable residues 
on the surface of the protein. If this change occurs in the active site or close to it, a change in 
the bond and / or conversion of substrates is possible, and when the change in dielectric 
constant is dramatic, three-dimensional structure of the enzyme can be transformed.  
The addition of substrates and the formation of products during the reaction may also change 
the hydrophobicity of the environment and, consequently, the water content around the 
enzyme. In our work we chose to use the cyclohexane, although similar results were obtained 
with isooctane. 
 
3.2.4  Water content of organic medium 
As known, water plays a key role in biocatalysis in organic environments, since it is involved 
in noncovalent interactions essential for maintaining the active conformation of the enzyme 
molecule. 
The addition of water to solid enzyme preparations in organic solvents can increase the 
activity of enzyme by increasing the polarity and flexibility of the active site. However, the 
excess water facilitates the aggregation of the enzyme and may cause a decrease in its 
activity. The amount required for maintenance of enzyme structure varies with the nature of 
the enzyme. 225 The hydration of polar and charged groups of molecules of enzyme seems to 
be a prerequisite for enzymatic catalysis. It’s possible that without water, these groups 
interact to produce a structural conformation inactive. The function of water  in the 
maintenance of enzyme activity in a non aqueous environment, appears to be related with its 
ability to form hydrogen bonds with these functional groups, thus electrostatic interactions 
between groups ionize dipole-dipole interactions between unit peptide and near polar groups 
of protein. Since water is distributed between different phases, it is useful to describe the 
water in the system in terms of water activity, “aw”, where the aw of a system "sealed" is 
often given by the ratio of its vapor pressure (Pw) and vapor pressure of pure water (P° w): 
aw = Pw / P° w. The “aw” should be adjusted to obtain optimal activity of an enzyme. This 
can be achieved through the use of salt hydrates that facilitate the exchange of water with the 
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system. Some pairs of hydrates salts may be effective in achieving the desired value of aw226 
(Table 16). 
 
Salta aw  Salt-hydrate pair aw 
LiCl 0.113  NaI anh./2H2O 0.12 
MgCl2 0.328  Na2HPO4 anh./2H2O 0.16 
K2CO3 0.432  NaAc anh./3H2O 0.28 
Mg(NO3)2 0.529  NaBr anh./2H2O 0.35 
NaBr 0.576  Na4P2O7 anh./10H2O 0.49 
NaCl 0.753  Na2HPO4 · 2H2O/7H2O 0.61 
KCl 0.843  Na2SO4 anh./10H2O 0.80 
K2SO4 0.973  Na2HPO4 · 7H2O/12H2O 0.80 
In equilibrium with a saturated salt solution, at 25°C  
Table 16 
As the catalytic efficiency of an enzyme depends on the value of aw,227 we decided to use a 
mixture of salt Na2HPO4 · 2H20/7H20 to obtain an intermediate value of aw (0.61). This 
condition was achieved by placing the solvent and the enzyme, for 24 hours, under stirring in 
a closed chamber in indirect contact with a saturated aqueous solution of salts (3g/20ml 




This time is considered sufficient to achieve equilibrium in water solution at room 
temperature. 
 
3.2.5  Concentration of substrate 
As expected, high concentrations of hydroxyester appear to favour inter-molecular reactions 
and are not favourable to the formation of monolactone. 
In order to check this aspect  we evaluated the reactions conducted on 1 mM and 5 mM of 
substrate. Results (Fig. 27) demonstrated that optimum concentration to lactonize methyl 16-
hydroxy hexadecanoate is 1 mM while 5 mM concentration is unfavourable in obtaining the 
desired monolactone and leaded preferencially to polymeric products. 
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3.2.6  Temperature 
We tested the effect of temperature in enzymatic reaction of synthesis of hexadecanolide. As 
in literature there are evidences that enzymes in organic solvents appear to be thermostable,  
we performed reactions at 40° C and 65°C. Several trials were conducted at different reaction 
time (Fig. 28).  For short times (15’-30’) we didn’t note marked differences between results 
obtained at both temperature, while after 1h the reaction at 40°C was by far the most 
efficient. In fact, the yield in hexadecanolide at temperature of 40°C in 1h, reached 79% while 










Comparison between 40°C and 65°C temperature with Enzyme CALB at 1mM concentration 
 
3.2.7  Reaction time  
The tests were conducted in a range of time from minutes up to 24 hours. The evolution of 
the lactonization of the substrate showed that the enzyme acts in a relatively short time; In 
fact, as shown in Table 17, a decreasing trend over time was observed, during which 
















 Comparison between 1mM and 5mM concentration with Enzyme CALB at 40 °C 
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1h. These results weren’t consistent with what reported in the literature 205 were high yields 
are described for reactions carried out for long time (up to 72h).    
 Time Yield %  
15’ 66 
30’ 69 
1 h 79 
2 h 76 
3 h 74 
6 h 69 
8 h 50 
24 h 40 
 
Table 17 
Variation in time of yield at 40°C with Enzyme CALB at  
1mM concentration of methyl 16-hydroxy hexadecanoate. 
 
3.2.8 Ciclization of 16 hydroxy decanoic acid 
In literature are reported some enzymatic lactonizations using hydroxy acid, instead esters. 
So we performed reaction with 16-hexadecanoic hydroxy acid (85) as substrate (scheme 29), 
in the same condition of developed methodology. Results showed a clear reduction in 
efficiency of cyclication compared to the corresponding hydroxy ester (Fig.29). In fact, after 








































Comparison of  variation in time of yield at 40°C with CALB at 1mM 





3.2.9 Ciclization without biocatalyst 
In order to prove the essential role of enzyme, we performed reactions using the usual 
conditions but without enzyme. There were no phenomena of cyclization of methyl 16-
hydroxy hexadecanoate in absence of lipase (Scheme 30). The reaction was monitored for 









3.2.10 Recovery of enzyme 
One of the advantages in using immobilized enzymes is their recovery from reaction 
environment. We evaluated this aspect by filtering the enzyme at the end of each reaction. 
Recovered enzyme was then introduced in the reaction flask in order to react with a new 
solution of substrate, for the same time and same temperature. 
Recovery operations were performed for 4 times; after fourth filtration it was noted that the 
enzyme had lost the initial particle size, indicating that acrylic resin was ruined.  
However, after 4 recovery, CALB showed sufficient activity for synthetize hexadecanolide 
giving a yield of 58% (Table 18). Additional recovery with satisfactory yields would have 
been probably  possible if we had used more mild stirrer instead that magnetic stirrer.  
 
Yield of Hexadecanolide 
Initial reaction 1st recovery 2nd recovery 3rd recovery 4rt recovery 




3.2.11  Summary of results 
The evaluation of all these parameter allows the following conclusion for the optimum 
conditions for lactonization to hexadecanolide from methyl 16-hydroxyhexadecanoate: 
 Establishment aw for enzyme activation (solvent and enzyme with saturated 
solution of salt hydrate pair for 24 hours). 
 Enzyme: Candida antarctica lipase immobilized on acrylic resin 
 Concentration: 1 mM 
 Solvent: Cyclohexane 
 Time: 1h 
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 Temperature: 40 ° C 
 
The optimized methodology can be now applied to lactonization of other ω-hydroxy esters. 
Furthermore, in our work, the enzymatic intraesterification based on developed condition has 






3.3 Macrolactones from ω-hydroxy esters. Synthesis of musky compounds 
The synthetic protocol developed for obtaining hexadecanolide from 16-hydroxy 
hexadecanoic ester was applied to the lactonization of some long chain ω-hydroxy esters. The 
odour of musk has been highly valued since immemorial time. Odorous compounds1 play an 
important role in life processes. The odorous compounds, first used in religious ceremonies, 
have been used for centuries as pharmaceutical ingredients and odorants. Three musky 
macrolactones of vegetable origin, hexadecanolide, exaltolide and ambrettolide, are very well 
known. However, these compounds are found as intricate mixture in nature and in minute 
quantities. The constant demand for these musks odorants in perfumery industry, has led to 
develope artificial musks. However, the artificial musks, as nitroaromatic compounds and 
polycyclic musks are either suspected to be carcinogenic or nonbiodegradable. Hence, in 
recent years, the demand for artificial musks is fading whereas synthetic natural musks are 
gaining importance. Actually, industrial process to synthesize these  compounds are based on 
methodologies that are characterized by their objective hazard. For example, in the Story´s 
synthesis, used for preparation of exaltolide and hexadecanolide, hazard formation and 
thermal decomposition of trisperoxide are key steps. We decided to apply enzymatic 
lactonization to the synthesis of hexadecanolide (85), exaltolide (3) and ambrettolide (4) as a 
green approach to their preparation. 
 
3.3.1 Hexadecanolide 
Dihydro-ambrettolide, hexadecanolide (72), although  significantly less musky and less 
tenacious than ambrettolide, has also found its way into the perfumers armoury of raw 
materials.  
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Application of enzymatic lactonization on methyl 16-hydroxy hexadecanoate has been already 
described being object of development of our methodology. Results have demonstrated that 
lipase CALB catalyzes hexadecanolide formation by a very simple step in high yield (79%) 





 Exaltolide (Cyclopentadecanolide), was isolated for the first time from the root of 
Angelica  archangelica (Fig.30); exaltolide, having musk-like odour and fixative properties is 
highly valued in the perfumery industry. 
 
          
Angelica archangelica  
Figure 30 
 
Several syntheses of 3 have been reported in the literature, including a Japanese patent which 
reports the acquisition of 77.8% of exaltolide obtained using lipase from Pseudomonas P in 
benzene at 30°C for over 24 hours, starting from a solution of 15-hydroxy pentadecanoic 
acid.228 










mM / T / t / aw
Exaltolide (3)






Compound 86 was obtained by Fisher esterification of 15-hydroxy pentadecanoic acid (70). 
Lactonization of methyl 15 hydroxy pentadecanoate (86), using our conditions, furnished 


























Variation in time of yield at 40°C with Enzyme CALB at 1mM concentration of 7. 
 
Several macrolactonizations were conducted at different times in order to look for the best 
yield. A maximum was reached after 2h, then a progressive decrease was observed up to a 
stable value which suggests the establishment of a balance between monolacton and starting 
hydroxy ester. Various tests were also carried out to determine whether higher 
concentrations of substrate could have a significant effect in terms of quantity of monolacton 
obtained. Result at 5mM concentration, however, have confirmed a substantial reduction in 
yield of exaltolide, according to previous result observed for hexadecanolide. 
 
3.3.3 Ambrettolide 
(Z)-16-Hexadec-7-enolide (ambrettolide®) (4) is the principal odorous constituent of  Hibiscus 
abelmochus, isolated from ambrette seed oil by Kerschbaum in 1927.229 Owing to their 







Hibiscus abelmochus  
Figure 32 
 
The compound used in perfumery today is of synthetic origin and is an isomer of the natural 
product: (E)-16-hexadec-9-enolide (isoambrettolide®).  
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The retro-synthetic scheme we have developed for the synthesis of (Z)-16-Hexadec-7-enolide 
(Ambrettolide ®) (4) is depicted in scheme 32. The unsatured hydroxy ester needed for 
enzymatic lactonization (93) was envisioned as obteined by Wittig reaction. Z-selective 
olefination by Wittig reaction of aldehyde 89 with the phosphorane derived from 
triphenylphosphonium salt 91 appeared to offer the most convergent assembly of 94. In turn, 
81 comes from reduction with Dibal-H of hydroxy ester 88, that is originated by protection 








































The synthesis started with protection of alcohol group of 87 with a solution of tert-butyl 
dimethyl silyl chloride with imidazole in dry dichloromethane, at room temperature; the next 
step was the carefully reduction of 88 to aldehyde 89. In order to reach an intermediate 
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degree of oxidation, it is necessary to pay attention to the addition of the reducing agent to 
avoid transformation of the ester 88 in alcohol. With most reducing agents, carboxylic esters 
give the primary alcohols and not the corresponding aldehydes. In case of complete reduction 
to alcohol, reoxidation to aldehyde, is often carried out. As alternative to this lengthy two 
steps procedure, the partial reduction of carboxylic esters with Dibal-H, has been reported. In 
our experiment, a careful addition of a diluted solution of Dibal-H to a diluted solution of 
ester in dry dichloromethane,  in two hours at -78°C, allowed to obtain a mixture whose main 
product was the desired aldehyde (scheme 33). 
t-BDMSi cloride
Imidazole



















Ethyl 7-bromo heptanoate (90) was transformed in the phosphonium salt 91 under reflux, at 
90°C for 48h in presence of triphenylphosphine in 90% yield (scheme 34).  
PPh3
CH3CN













The subsequent step was olefination by Wittig reaction, followed by deprotection of alcohol 
group (scheme 35). In the Wittig reaction the phosphonium ion is deprotonated by potassium 
of bis(trimethylsilil)amide and dry THF was used because such strong base requires 
moisture-free conditions. Once the strongly nucleophilic carbanion/ylide is formed, attacks 
aldheyde’s carbonyl just like other strong nucleophiles, producing an alkoxide. This rapidly 
closes onto the phosphorus to form a 4-membered ring, which rapidly fragments to give the 
desired alkene and triphenylphosphine oxide as a side product. 
One interesting aspect of Wittig reactions is that normally the carbanion/ylides are colored, 
often intensely (many are a deep, blood red or sometimes grape-juice purple) while the 
product alkene and phosphine oxides are normally not colored. Thus it could be possible 
often monitor Wittig reactions by observing the color of the solution. In our experience, only 
a sluggish fade of the orange-red color of ylide was observed and TLC was used for 
monitoring when the ylide has reacted and gone on to final products.  
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At the end, the olefin Z-92 was formed exclusively and isolated in yields of 60%. The 
geometry of double bound was evaluated by observing the coupling constants between vinylic 
protons in H-NMR spectra (J=9.2 Hz). Subsequent removal of t-BDMSi protecting group 



















With hydroxyl ester 93 in our hand, we were ready for the cyclization step. Enzymatic 
lactonization of 93, was conducted in presence of CALB immobilized on acrylic resin and  
under the estabilished conditions of developed methodology (scheme 36). The best yield, 79% 
of (Z)-16-Hexadec-7-enolide (ambrettolide ®) 4, was obtained after 3h. 
CALB








Again we found that the enzyme acts immediately on hydroxy ester which begins to lactonize 
already in the first few minutes until it reaches the maximum in terms of percentage yield of 


























3.4 Macrolactones from hydroxyester owning secondary alcohol 
Lipase B from Candida Antarctica (CALB) has found several application as a catalyst in kinetic 
resolutions.231 However, all these investigations were directed to study intermolecular 
reactions between a secondary alcohol and a carboxylic acid (ester), while in a 
macrolactonization process both reacting moieties are part of the same molecule. Starting 
from these considerations, we wanted to test the reactivity and the enantioselectivity of 
CALB in lactonization reactions of hydroxy esters owning a secondary alcohol. For our 
investigation we choose as synthetic targets 15-methyl hexadecanolide and 15-propyl 




3.4.1  Chemo-enzymatic synthesis 15-hexadecanolide 
Male-released pheromones of the stink bug Piezodorus hybneri (Heteroptera: Pentatomidae) 
(Fig.34) were isolated from the airborne volatiles of 
males by flash chromatography, with the activity 
monitored by GC-EAD and behavioral bioassay. The 
pheromone system was characterized as a mixture of 
three active compounds including (R)-15-methyl 
hexadecanolide. 232 
Enantiomerically pure samples of the R and S 
macrolactone were obtained by Yamaguchi's and 
Mitsunobu's macrolactonization of a key intermediate, 
(R)-15-hydroxyhexadecanoic acid. 232,233 The unnatural S stereoisomer was neither a 
beneficial nor a behavioural antagonist. Individual constituents or binary mixtures were 
active, but the optimal male response was elicited only by the full mixture. Behavioural 
observation and the fact that the onset of pheromone production is coincident with ovarian 
development strongly suggest that these semiochemicals are, in fact, sex pheromones. 
The retro-synthetic scheme follows a similar approach previously described for the synthesis 
of ambrettolide (Scheme 37). The desired lactone 103 derives from hydrogenation of lactone 
102 which can be obtained by lipase catalyzed lactonization on 101, an hydroxy ester 
unsatured with double bond in Z stereochemistry. This hydroxy ester results by olefination 




Piezodorus hybneri  
 71 
triphenylphosphonium salt 96. In turn, 99 comes from reduction with DIBAL-H of hydroxy 
ester  98, that is originated by protection of alcohol group of 97 with a tert-butyl dimethyl 
silyl chloride solution. Instead, fragment 99 is a phosphonium salt obtained starting from 95, 
obtained by Fisher esterification on 12-bromo dodecanoic acid 94.  
In order to ascertain the enantioselectivity of enzymatic lactonization we used racemic 
















































In the first part of the synthesis the two reagents needed for the Wittig reaction were 
prepared. At the beginnig of the synthesis, the secondary alcohol group of  rac-3-hydroxy 
butyrate 97 was protected using a solution of tert-butyl dimethyl silyl chloride with imidazole 
in dichloromethane dry, at room temperature, obtaining 95% of 98; this ester was then 
reduced to aldehyde 99, by slow addition of a diluted solution of Dibal-H at -78°C 
(CO2/acetone bath). In about two hours we obtained a mixture whose main product is the 















98 9997  
 
Scheme 37 
The preparation of phosphonium salt 96 starts with Fisher esterification of bromoacid 94 to 
give 12-bromo dodecanoate methyl ester (95). Then, bromoester 95, in the presence of 























The subsequent step was olefination by Wittig reaction, using potassium of 
bis(trimethylsilil)amide in  THF dry. Anhydrous conditions are essential for effective 
formation of ylide. Thus, the phosphonium salt, anhydrified with dry toluene, was dissolved, 
under nitrogen, in dry THF. Then the solution of potassium bis(trimethylsilil)amide in  THF 
was added dropwise and the solution was stirred for half an hour until ylide (orange dark 
color) was formed. At the end, the olefin Z-100 was exclusively formed and isolated in yields 
of 60%. Subsequent removal of t-BDMSi protecting group was done using 48% aqueous 























Enzymatic lactonization of 101 was conducted according to the conditions of the developed 
methodology and gives 41 % of 15-methyl hexadecenolide 102 after 3h. The reaction time 
was optimized conducting several reactions (Figure 35). 
The subsequent hydrogenation with Pd/C under pressure of hydrogen for 1 hour leads to 
90% of 103 (scheme 41).  
CALB
Controlled conditions

































Variation in time of yield at 40°C with Enzyme CALB at 1mM concentration of 101 
 
When we measured optical rotation of the obtained lactone we found a negative value 
( [ ] 7.13 25 −=
D
α ). Therefore, starting from a racemic substrate, optical active lactone was 
obtained. In particular the negative sign of the measured optical rotation indicates that (R)-
15-methyl exadecanolide is the main component obtained. In fact the measured optical 
reported for (R)-15-methyl exadecanolide (103), obtained by other synthetic routes, is  
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[ ] 2.18 25 −=
D
α .  
This result confirms the enantioselectivity of the enzyme in agreement with the reported 
empirical rule of Kaslaukas which for a resolution of racemic secondary alcohols by lipase 
catalyzed esterification indicates the R enantiomer as the faster one. 94 
However, the issue about the presence of the lactone derived from the slow reacting substrate 
remains to be solved. In fact, it is well known that the success in enzymatic kinetic resolution 
depends on the careful control of the reaction times. We firstly tried to calculate the e.e. of the 
obtained product by HPLC using chiral column. In this analysis we were able to detect only 
one peak but this doesn’t exclude the presence of both enantiomes in the same peak eventually 
due to scarce separation in our condition. At this point we considered the analysis of the 
mixture of alcohols recovered at the end of reaction. However, derivatization by Mosher's 
method followed by spectroscopy NMR analysis did not allow us to determine e.e. In fact, 
two set of signals, with marked different intensities, were observed but  with great 


















Chromatographic analysis in HPLC using chiral column on the products obtained by Mosher 
esterification showed that the unreacted alcohol mixture was rich in S-enantiomer (see 
experimental). This indicates that R-isomer did not reacted completely but doesn’t exclude 
that a small part of S-enantiomer could have reacted. 
These results were not conclusive so we decided to virify the enantioselectivity of the reaction 
synthesizing the (R)-101 and (S)-101 starting from the two pure enantiomers ethyl (R)-3 
hydroxy butyrate (R)-97 and ethyl (S)-3 hydroxy butyrate (S)-97, using the same synthetic 



























































































1. BuLi, THF dry
















With (R) and (S) 15-hydroxyhexadecenoic ester in our hands, we could submit them 
separately to enzymatic lactonization. It was found that only R-enantiomer is capable of 
lactonization after 1h (scheme 44) while S-enantiomer was recovered unreacted in the same 
conditions. Furthermore, even after 24h no lactone formation was detectet using (S)-101. 
From these data we can conclude that the lactone obtained, by enzymatic lactonization of 































3.4.2 Synthesis of 15-octadecenolide 
Studies on lipase catalyzed esterifications have shown that enzymatic activity is strongly 
influenced by substituents of alcohol. In fact, it has been proposed that for long chain 
secondary alcohols high activity is found when the medium substituent (M)  is smaller than n-
propyl (see section 1.2.6).  In order to verify this influence we considered the enzymatic 
cyclization of propyl 15-hydroxy pentadecenoate (111).  
The retro-synthetic scheme follows the same way developed for the synthesis of 15-
hexadecanolide (Scheme 46). The desired lactone 112 derives from lactonization catalyzed by 
CALB on 111, an hydroxy ester unsatured with double bond in Z stereochemistry. Protected 
compound 110 can be obtained by Wittig olefination using aldehyde 109 and the 
phosphorane derived from triphenylphosphonium salt 106. In turn, 109 comes from 
reduction with DIBAL-H of hydroxy ester 108, originated by protection of alcohol group of 
ethyl (R,S)-3-hydroxyhexanoate (107). Instead, fragment 106 comes from 105, obtained by 











































108 was prepared by simple protection of the alcohol group of ethyl (R,S) 3-hydroxy 
exanoate (107) using a solution of tert-butyl dimethyl silyl chloride with imidazole in dry 
dichloromethane, at room temperature. In the following step, the reduction to aldehyde 109, 
the reducing agent was added very slowly in a CO2/acetone bath, to avoid transformation of 
the starting ester in alcohol. Thus, a diluted solution of Dibal-H was added to a diluted 
solution of ester 108 in dry dichloromethane, dropwise in two hours at -78°C. In this way it 










































Finally, olefin (Z)-110 was prepared, in 60% yields, by Wittig reaction between 106 and 109, 






















Enzymatic lactonization of 111, conducted in presence of CALB immobilized on acrylic resin 
and under the estabilished conditions of developed methodology,proved to be very slow and  
gave, after 96h, 15-octadecenolide (112) with a yield of 26% (scheme 49).  Thus, cyclization is 
slower when the size of substituent linked to chiral carbon is equal or larger than propyl.  
This result is consistent with the model described by Roticci in which the enzyme provides 
space enough to accommodate a substituent smaller than an n-propyl group. 
CALB
Controlled conditions








In conclusion, we can observe that the model for the active sie of CALB described studing 




3.5 Macrolactones from di-hydroxy esters  
One of the problem encountered in the synthesis of a macrolacton starting from a di- hydroxy 
ester (or acid) is related to the regiocontrol of the reaction. In some cases the size of the cyclic 
compound to be formed can control its formation. Sometimes, it appears that 
macrocyclization is favoured if a properly conformation is easily adopted during cyclization. 
For example, selective macrolactonization has been described for the synthesis of 
polycavernoside, a macrolide isolated by Yasumoto from the red alga Polycavernosa tsudai and 
showning to posses lethal toxic properties.234 Macrolactonization,using Yamaguchi 
methodology, afforded exclusively 143 resulting from closure at the C15 hydroxyl group, 





















Scheme 50  
Yamaguchi lactonization in the total synthesis of polycavernoside. 
 
However, a part few cases,  generally when more than one macrolide can be formed, the 
solution consists in the protection of the alcoholic function whose reaction is unwanted in 
order to allow macrolactonization only on the free alcohol position. Of course, a deprotection 
step is then needed in order to obtain the desired hydroxy macrolacton. However, this 
procedure requires the incorporation in the synthetic strategy of two additional steps 
(protection, deprotection).  
In this context an investigation was undertaken on the ability of lipases to control the 
regiochemistry of macrolactonization reaction. This expected behaviour was based on the 
specific constrains required by the catalytic site of the enzyme.  
Really, in literature the only reported results on the regioselectivity of lipase are related to 
regioselective acylations of 1,n-diols. 235 In these cases, a regioselective acylation of a primary 
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hydroxyl group is observed, allowing discrimination between primary and secondary 
alcohols.  
For our study lipase catalyzed macrolactonization for the synthesis of aleuritic lactone and 
the synthesis of aplyolides were chosen. 
 
3.5.1 Lactone from poly-hydroxylated substrates: synthesis of aleuritic lactone  
In order to apply regioselectivity of CALB towards poly hydroxylated substrates, we 
conducted a lipase catalyzed reaction starting from erythro-aleuritic ester, prepared by Fisher 
esterification from corresponding acid. The ester 144  showed low solubility and thus the 
lactone was obtained in poor amount. In order to overcame this problem, we tried to improve 
the solubility by dissolving the ester adding few microliters of acetonitrile and using high 
temperature (65°C). In these conditions, lactonization was possible, leading to formation of 




















3.5.2 Synthesis of aplyolides B and D 
 
With the aim to study the competition between two secondary alcohols we decided to aplly 
our methodology to the synthesis of aplyolides. 
Aplyolides B and D are two ichthyotoxic macrolactones, isolated from the marine mollusk 
Aplysia depilans,122 containing 18 carbon atoms, characterized by two homo-conjugated double 
bonds and two stereogenic centers of absolute configuration S at C-15 and the C-16. They 
derive from the cyclization, respectively at C-15 and C-16, of the same precursor, the 15(S), 
16(S)-dihydroxy octadeca-9 (Z), 12(Z)-dienoic acid. They look like very thick light yellow oil 
with the following optical rotatory power: [ ] 8.42 25 −=
D
α , for the aplyolide B, and [ ] 2825 +=
D
α , 
for the aplyolide D.  
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Figure 36 
Retrosynthetic analysis follows a convergent approach (scheme 52). The first step is the 
breaking of the ester bond to form compound 120. Dihydroxyacid is derived from the 
compound 119, where two double bonds in Z stereochemistry have been converted to triple 
bonds. The next disconnection of dynoate splits in fragments 115 and 118, comparable in 
size, which, when properly protected, will be paired in the synthetic route by coupling 
reaction via nucleophilic substitution. The first of the two fragments, 115, contains two 
stereogenic centers of S configuration introduced by asymmetric dihydroxylation on alchene 
stereochemically E, 114. This fragment can be generated by the corrisponding alcohol (113), 
which can be further disconnected to propargyl alcohol and 1-bromo-pent-2(E)-ene. 
Compound 118 will be derived  from  esterification of 117 which is easily obtained by 
oxidation of alcohol 116; this last one is directly obtained from decyn-1-3-ol, by “migration” 
of the triple bond. 
The synthesis begins with a first coupling, involving 1-bromo-pent-2-(E)-ene and propargyl 
alcohol, followed by the bromination of the mixture of the two alcohols, 113 and 113 * and 
the dihydroxylation on the obtained mixture of bromides, 114 and 114 *. The double bond 
stereochemistry of the compound 114 is suitable for the reaction of Sharpless asymmetric 
dihydroxylation (A.D.), to obtain the compound 115 (scheme 53).236,237 The use of ligands, 
such as the phtalazine (Phal), and the presence of sulfonamides accelerating the hydrolysis of 
organic esters of osmium, have recently improved the application of this reaction, allowing 
the development a procedure for a wide range of olefinic substrates. For our enantioselective 
synthesis, we used the AD-mix-α™, a preparation of standard reagents that achieves two 
centers in carbinol stereochemistry S. For this diol, the absolute configuration was assigned 
in accordance with the rule of "AD face-selection”. The mixture is commercially available, 
however, affordable only for small-scale reactions (up to 5mmol).   The  conversion of 1 mmol 













































































0.980g of K3Fe(CN)6, 0.410g of K2CO3, 7.8 mg of (DHQ)2-Phal (or (DHQD)2-Phal for AD-
mix-β™), 0.74 mg K2OsO2(OH)4 as a non-volatile source of  osmium.The process actually 
took only catalytic amount of OsO4 and one of the two diastereoisomers of a chiral amine, 
such as dihydroquindine (DHDQ) or dihydroquinine (DHQ). DHDQ and DHQ are 
diastereoisomers and not enantiomers: the two alkaloids "pseudoenantiomeric" give diols of 
opposite configuration, but with e.e. usually not identical. To limit the catalytic amount of 
expensive and toxic OsO4, is used a secondary oxidant able to form osmium in situ. This is 
the potassium ferrocyanide which is located in stoichiometric amounts in a biphasic mixture, 
together with potassium carbonate. Coordination to osmium of the chiral ligand amine, 
(DHQ)2PHAL, leads to the formation of a stable chiral adduct that can distinguish between 
the two faces of the prochiral olefin substrate, leading to the formation of the cis-diol on one 
side than the other. The degree of e.e. reflects the skill with which this complex can 
distinguish between the two prochiral faces of alkene thanks to the difference in energy of the 
transition states of resulting diastereoisomers. However, use of methansulphonamide cause 
dihydroxylation of only the desired compound, as in his presence, terminal olefins react very 
slowly. In this way, even if 113 cannot be separated from its isomer, does not react within 20 
hours and is separated at this time.  
The yield of 115 is 60%, with an enantiomeric excess of 95%, as estimated by HPLC.  
The fragment 38, containing a terminal triple bond and an ester group, is obtained starting 
from 3-decyn-1-ol. 9-decin-1-ol, 116, was prepared by the reaction of triple bond migration 
on 3-decyn-1-ol, using NaH in 1,3-diaminopropane (DAP).238 In these circumstances,  
bifunctional "Superbase", 3-aminopropilamide, is formed. The 3-aminopropilamide is 
completely soluble in the excess of amine from which it derives: this high solubility may 
result from solvation power of the diamine and / or "internal solvation" amide itself. The 
reaction involves a multi-position rapid isomerization of the triple bond which, at the end of a 
process with a series of alkyne-allene interconversion, remains locked at the end of the chain. 
This migration to the end position is "anti-thermodynamics", since, at equilibrium, the 
internal alkynes are thermodynamically more stable. In fact, the driving force that moves the 
balance involved in the base mediated isomerization, is the precipitation, once formed, of 
alkaline acetylide. Better efficiency is attributed to KH: more reactive (isomerization 



















Scheme 54 : Isomerization of triple bond in presence of NaH and 1,3-diaminopropane (DAP). Down is shown 
the mechanism “zipper” of superbase, the 3-aminopropylamide, that migrates along carbonious chain.  
 
Therefore, 3-decyn-1-ol, in the presence of strong base, transposes at 55°C, gave the sodium 
salt of terminal alkyne, and the subsequent acidification produces 9-decyn-1-ol with a yield of 
95%. Subsequently, 9-decynoic acid 117 is prepared by oxidation of alcohol function with 




















The next step provides 119 by direct coupling between 115 and 118 using the procedure 
already described for the other couplings. Finally, hydrogenation using Pd/BaSO4 as catalyst 






















Scheme 56 : Synthesis of 120 . 
 
 
15(S),16(S)-dihydroxy-octadeca-9(Z),12(Z)-dienoic acid (120) was transformed into lactone 
via the enzymatic method developed and described in previous chapter. The reaction, 
monitored chromatographically, leads to the synthesis of smaller size aplyolid (28) (with 













Lactonization reaction was very slow and needed of long time for obtain 28 in appreciable 
amount. This result confirms that (S,S)-120 is the slow reactant enantiomer, according with 
previous observed enantioselectivity of CALB. Moreover, even in long time, there was noted 
no evidence of dimer formation. 
Compounds obtained have spectroscopic characteristics consistent with those described in the 
literature.  
 
3.5.3 Synthesis of  enantiomers of aplyolides B and D 
With the aim to verify the enantiomeric preference of CALB we undertook the 
enantioselective synthesis of enantiomers of aplyolides B and D. We followed a retrosynthetic 
similar to scheme 52. The only step that differs from that reported for the synthesis of 
aplyolides B and D was the use of AD-mix-β™, for the Sharpless asymmetric 




















Lipase catalyzed synthesis of enantiomers of aplyolides B and D. 
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Starting from (R,R)-123 enantiomer, lipase catalyzed lactonization afforded in one hour 
larger aplyolide (124), in constrast to that observed for (S,S)-enantiomer which producted 

























Results of lactonization to enantiomers of aplyolides B and D. 
 
 
3.5.4 Synthesis of Aplyolides C and E  
 
The aplyolides C (28) and E (29) are two macrolactones with 18 carbon atoms characterized 
by three double bonds homo-conjugated and two stereogenic centers of absolute 
configuration S at C-15 and the C-16. They derive by cyclization, respectively, at the C-15 
and C-16 of the same precursor, the 15(S),16(S)-dihyidroxyoctadeca-6(Z),9(Z),12(Z)-tryenoic 
acid, 135. They appear as very dense yellow oil with the following optical rotatory power: 
[ ] 7.2625 −=
D
α  for the aplyolide C and [ ] 3.4625 +=
D
α  for the aplyolide E5. 
The two lactones aplyolides C and E differ from B (26) and D (27) only for the presence of 
further double bond at C-6. Compared with the synthetic route adopted for B and D, the 
synthesis of aplyolides C (28) and E (29) requires an extra step for the introduction of the 
third triple bond and isomerization reaction of the triple bond was no longer necessary. In the 
synthetic strategy used, in addition, the portion with the two stereogenic centers was used as 
a terminal acetylene in the coupling reaction and not as a halide. The analogy with the 
previous retrosynthetic schemes is evident. Once again, the precursor of the polyene is a 
poliynic system, the triyne 133. While fragment 128 derives from coupling of 1-bromo-pent-
2(E)-ene (126) with trimethylsilyl-acetylene (127), compound 133 is obtained from coupling 






































Retrosynthetic scheme for aplyolides C (28) and E (29) 
 
The stereogenic centers of 130 are once again introduced by Sharpless asymmetric 
dihydroxylation.  
 As provided in Scheme 60, we proceed to the synthesis of fragments 130 and 133. The 
first reaction of the synthesis is based on a nucleophilic substitution made by the 
trimethylsilyl-acetylide on 1-bromo-pent-2-(E)-ene: under normal conditions, the compound 
128 is obtained with its isomer 128*. The mixture of the two, in a 2:1 ratio, then is subjected 
to the subsequent Sharpless dihydroxylation (scheme 60). 
 
Scheme 60 : In scheme isomers 128 and 128* are obtained and made to react in mixture of 2:1. The e.e. 




























Differently from the synthesis of analogous 114, here we saw that after only five hours also 
128* began  to react. The total yield of 129 is 60% in two steps. The diol is then deprotected 
in the presence of a solution of tetrabutylammonium fluoride. 
133 was subsequently prepared using a coupling reaction between 4-chloro-2-butyn-1-ol and 








Scheme 61 : Reagents and conditions:  a) Cs2CO3, CuI, NaI, DMF, 90%;   b) CBr4, PPh3, CH2Cl2, 85%. 
 
 
Synthetic sequence for the synthesis of dihydroxyester 135 and aplyolides C and E, followed 
the usual scheme: coupling reaction, reduction obtained triyne, 134 and enzymatic 









 H2, Pd/BaSO4,       
chinolina, MeOH
90%





The reaction, monitored chromatographically, led to the synthesis of smaller aplyolide E (29), 
with presence of traces of aplyolide C, in 48 hours at 40°C in yield of 39% (Scheme 64). There 
was no evidence of dimer formation. 
The compounds obtained showed spectroscopic characteristics perfectly in agreement with 













As previously observed in the synthesis of aplyolides B/D from di-hydroxy ester at 
stereochemistry S,S smaller lactone  (E) was obtained. 
 
 
3.5.5 Synthesis of enantiomers of aplyolides C and E  
Similarly, we proceeded to the synthesis of enantiomers of aplyolides C and E following a 
retrosynthetic scheme in which the only step that differs from that reported for the synthesis 


















Scheme 64 : Chemoenzymatic synthesis of enantiomers of aplyolides C and E. 
 
Lactonization of 138 shows, also in this occasion, that R,R-138 is the fast reactant enantiomer 
which led to obtain 81% of enantiomer aplyolide C after 3h, at 1mM and 40°C (Figure 38). As 
previously observed in the synthesis of enantiomers of aplyolides B/D, using di-hydroxy 

























Results of lactonization to enantiomers of aplyolides C and E. 
 
 90 
3.5.6 Macrolactonization of 15(R),16(R)-dihydroxy-octadecanoic acid methyl ester. 
It is well known that the presence of double bond in secoesters has an influence in 
macrolactonization.240 In order to study this effect on our substrates we decided to prepare 
15(R),16(R)-dihydroxy-octadecanoic acid methyl ester (141) for its lactonization via the 
enzymatic method developed and described in previous chapter. Compound 141 was easily 
obtained by hydrogenation of 138. 
The formation of larger lactone 142, as usually resulted from (R/R)-dihydroxy esters, was 
obtained from 15(R),16(R)-dihydroxy-octadecanoic acid methyl ester (141) (Scheme 66). 
However, t he reaction was very slow, giving after 3h only 36% yield of lactone. Longer time 
were required to obtain higher amount of lactone. Variation of yield at different reaction time 
is depicted in Figure 39. Only after 12h, lactone 142 was producted in over 60% of yield. 
These data suggest that the reaction is more difficult due to the absence of double bounds 

















































3.5.7 Final considerations on lipase catalyzed lactonization of dihydrohyesters 
The results obtained can be resumed as follows: 
1) Substrates containing unsaturations are more reactive than saturate ones. 
2) The enzyme CALB lactonizes R,R-dihydroxyesters faster than corresponding S,S-
substrate. 
3) Stereochemistry of stereocentres controls the regiochemistry of lactonization: R,R -
enantiomes give large lactone while S,S - enantiomers furnish the small cycle. 
 
This last result deserves a comment. It is really impressive how in these reactions the 
stereochemistry of secondary alcohol can direct the regiochemistry of the ring closure. 
However, considering the reported description of the active site of CALB we can propose 
an explanation of this result. We know that high activity of CALB is observed when one 
substituent (M) is an ethyl group or smaller and the other substituent (L) bigger than 
ethyl (Figure 40). When R,R enantiomer reacts we can imagine two productive binding 
modes (PBM): one for lactonization at C-16 (PMB I) and another for cyclization at C-15 
(PMB II). Only PMB for the formation of the largest ring contains the right sized 
substituents at the right pockets. When we consider the S,S enantiomer the needed 
orientation in the active site causes the presence of a group larger than ethyl in the 
stereospecificity pocket in both cases PMB III and PMB IV. However, PMB IV shows at 
list a L substituent larger than a propyl while PMB III in both pockets are filled with 
wrong substituents, being ethyl in the pocket generally requiring a substitient larger than 
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In this work an efficient methodology has been optimized for the enzymatic 
macrolactonization of hydroxyesters. The synthesis of several compounds has been 
accomplished using lipase CALB as biocatalyst. CALB catalyzed intramolecular 
lactonizations seems to fit very well with the proposed model of active site developed for 
intermolecular transesterification. The lipase catalyzed reactions on dihydroxyesters have 
shown an interesting regioselectivity directed by the stereochemistry of the alcoholic 
stereocenters.  
All these data show how lipase mediate macrolatonization, although with some 
























































All reactions were conducted, where the procedure demanded, in an inert atmosphere, using 
solvents anhydrified with proper drying, the glassware used was flamed under vacuum. The 
reactions were monitored by thin layer chromatography (TLC) and the products were 
visualized by UV light or by spraying of indicators, such as phosphomolybdic acid and cerium 
sulfate, or by exposure to iodine vapor. 
The products were purified using silica gel (Merck 70-230 mesh and Merck 230-400mesh). 
The NMR spectra were performed on Brucker AM 250 spectrometers (250.13 MHz for 1H 
and 62.89 for 13C), Bruker DRX 300 (300 MHz for 1H and 75 MHz for 13C) and Brucker DRX 
400 (400.135 MHz for 1H and 100.03 for 13C) of the Department of Chemistry, University of 
Salerno. The chemical shifts were reported in ppm: CHCl3 signal (7.26 ppm for 1H) and 
CDCl3 (77.0 ppm for 13C) were used as internal standard. 
Enantiomeric excess were measured by HPLC using a Modular HPLC System JASCO LC-
NET II/ADC equipped with a JASCO Model PU-2089 Plus Pump, a JASCO MD-2010 Plus 
UV–vis multiple wavelength detector and a Waters refractive index detector. 
ESIMS spectra were performed on a Micromass Quattro micro APITM mass spectrometer 
equipped with an electrospray ionization source operating in positive mode. IR spectra were 
obtained at a resolution of 2.0 cm-1 with a Vector 22 Bruker Spectrometer. Optical rotations 
were measured with a JASCO DIP-1000 polarimeter. Elemental analyses were performed on 


















4.1 Synthesis of 16-hexadecanolide 







16-Hydroxy hexadecanoic methyl ester (71) was prepared by Fisher esterification reaction. A 
solution of 16-hydroxy hexadecanoic acid (2mmol) in 10mL of methanol was acidified with 5 
drops of sulfuric acid 96% and refluxed at 70° C for 20 hours. After extraction with diethyl 
ether and water, ethereal phases were combined, anhydrified on Na2SO4 and concentrated 
under vacuum. The reaction is almost quantitative. The ester 71 was purified on silica, 
eluting with petroleum ether/diethyl ether 7/3. 
 
16-Hydroxy hexadecanoic methyl ester (71) 
1H-NMR (CDCl3, 400 MHz): δ  3.67 (3H, s, –OCH3), 3.53 (2H, m), 2.30 (2H, t, J= 7.5 
Hz),1.94 (1H, t, J= 2.7 Hz), 1.62 (2H, br t, J= 7.5 Hz), 1.48 (2H, m), 1.29 (22H, m). 
13C-NMR (100MHz CDCl3): δ  174.4 (s), 68.0 (t), 52.3 (q),  34.0 (t), 32.3 (t),  29.0 (t), 28.8 ( t), 
28.4 (t), 28.1 (t), 24.8(t), 18(t). 
 
 
4.1.2 Synthesis of 16-Hexadecanolide (72) 
72 
 
The reaction flask containing a solution of 50mg of enzyme (CALB Immobilized on acrylic 
resin) in 40mL of cyclohexane was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20). The flask was left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of hydroxy-ester 71 were added to the reaction 




At the end, the enzyme was removed from the solution by filtration and the filtrate was 
concentrated under vacuum. The crude was purified on silica and eluted with hexane / 
chloroform 6 / 4, affording 79% of 16-hexadecanolide (72).  
 
16-Hexadecanolide (72)  
1H-NMR (CDCl3, 400 MHz): δ  4.13 (2H, dd, J= 5.6 Hz, J= 5.2 Hz), 2.33 (2H, t, J= 6.6 Hz ), 
1.66 (4H, m),1.32 (22H, br s). 
13C-NMR (100MHz CDCl3): δ  173.4 (s), 67.0 (q),  34.4 (t), 32.3 (t),  29.9 (t), 27.4 (t). 
ES-MS (m/z)= 254 (M+).  
IR (cm-1): 2923, 2859, 1732, 1457, 1164 
 
 
4.2 Synthesis of exaltolide 





86 was prepared by Fisher esterification reaction. A solution of 15-hydroxy hexadecanoic acid 
(2mmol) in 10mL of methanol was acidified with 5 drops of sulfuric acid 96% and refluxed at 
70° C for 20 hours. After extraction with diethyl ether and water, ethereal phases were 
combined, anhydrified on Na2SO4 and concentrated under vacuum. The reaction is almost 
quantitative. The ester 86 was purified on silica, eluting with petroleum ether/diethyl ether 
7/3. 
 
15-Hydroxy pentadecanoic methyl ester (86) 
1H-NMR (CDCl3, 400 MHz): δ  3.67 (3H, s), 3.53 (2H, m), 2.30 (2H, t, J= 7.5 Hz),1.94 (1H, t, 
J= 2.7 Hz), 1.62 (2H, br t, J= 7.5 Hz), 1.48 (2H, m), 1.29 (18H, m). 
13C-NMR (100MHz CDCl3): δ  174.4 (s), 68.0 (t ), 52.3 (q ), 34.0 (t), 32.3 (t), 29.0 (t), 28.8 












The reaction flask containing a solution of 50mg of enzyme (CALB Immobilized on acrylic 
resin) in 40mL of cyclohexane was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20). The flask was left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of hydroxy-ester 86 were added to the reaction 
flask and it was immersed in a bath at 40° C, under vigorous agitation, for 1h. 
At the end, the enzyme was removed from the solution by filtration and the filtrate was 
concentrated under vacuum. The crude was purified on silica and eluted with hexane / 
chloroform 6 / 4, affording 88% of exaltolide (3).  
 
Exaltolide (3) 
1H-NMR (CDCl3, 400 MHz): δ  3.93 (2H, t, J= 5.2 Hz), 2.17 (2H, t, J= 7.0 Hz ), 1.66 (4H, 
m),1.32 (20H, br s). 
13C-NMR (100MHz CDCl3): δ  173.4 (s), 67.0 (t),  34.4 (t), 32.3 (t),  29.9 ( t), 27.4 ( t). 
ES-MS (m/z)= 240 (M+).  










4.3 Synthesis of ambrettolide 







Alcohol group was protected by reaction with t-BDMS-Cl. 
A solution was prepared by mixing 5.31mmol of 9-hydroxy nonanoate methyl ester, 7mmol of  
t-BDMS-Cl, 7mmol of imidazole and 5.3ml of dichloromethane dry. The reaction goes at room 
temperature, stirring vigorously, in 20h. 
50ml of H20 were added and the mixture was extracted with ethylic ether/H2O. Ethereal 
phases were anhydrified on Na2SO4, concentrated in vacuo and purified by silica gel 
chromatography, eluting with petroleum ether/ diethyl ether 97/3. 
96% of pure 88 is obtained. 
 
Ester 88 
1H-NMR (CDCl3, 400 MHz): δ  3.65 (3H, s, –OCH3), 3.58 (2H, m), 2.29 (2H, t, J= 7.7 Hz), 
1.62 (2H, m), 1.49 (2H, m), 1.29 (8H, m), 0.88 (9H, s), -0.03 (6H, s). 
 






5.1mmol of 88 were diluted with 10ml of CH2Cl2 dry. Then, under N2 atmosphere, during 2h, 
at -78°C (CO2/acetone bath), 5mmol of DIBAL-H (1.0M in CH2Cl2) diluted 1/1 with CH2Cl2 
dry, were added to solution. 
Subsequently, 10ml of a sature solution of Na/K tartrate were added to neutralize DIBAL-H; 
the mixture was extracted with diethyl ether/H2O. Ethereal phases were anhydrified on 
Na2SO4, concentrated in vacuo and purified by silica gel chromatography, eluiting with 
pentane/ diethyl ether 99/1. 
 100 
Aldehyde 89 was obtained in a yield of 80%. 
 
Aldehyde 89 
1H-NMR (CDCl3, 250 MHz): δ  9.75 (1H, s), 3.58 (2H, t, J= 6.5 Hz), 2.30 (2H, dt, J= 7.4 1.8 
Hz), 1.62 (2H, m), 1.49(2H, m), 1.29 (8H, m), 0.88 (9H, s), -0.03 (6H, s). 
13C-NMR (62.89 MHz CDCl3): δ  202.7 (d), 63.0 (t), 43.7 (t),  32.6 (t), 29.1 (t), 28.9 (t),   25.8 
(q, 3C),  25.5(t), 21.9 (t), 18.2 (t), -5.4 (q, 2C). 
 
 







A mixture containing 6.3mmol of 90 bromo ethyl heptanoate, 6.3mmol of triphenilphosphine 
and 15ml of CH3CN was placed under reflux, at 90°C for 48h. Then, at room temperature,the 
solution was concentrated in vacuo and purified by silica gel chromatography and eluted with 
petroleum ether/ diethyl ether 97/3 (to retrieve the starting bromo ester) and then with 
chloroform/methanol 95/5. 
Phosphonium salt 91 was obtained in a yield of 90%. 
 
Compound 91 
1H-NMR (CDCl3, 250 MHz): δ  7.77-7.64 (15H, m), 3.82 (2H, q, J= 7.1 Hz), 3.43 (2H, m), 



















5.1mmol of 91 were placed in a anhydrified flask and washed 3-4 times with toluene dry. 
Toluene was then removed in vacuo and flask was maintained under N2.  
10ml of THF dry were added to phosphonium salt at 0°C stirring for some minutes. At this 
temperature 5mmol of a solution of TMSA-K (0.5M in toluene) were diluted with 10ml of 
THF dry, are added to reaction flask; then the system was maintained at room temperature 
for 30 minutes.  
The system was freezed at 0°C and a solution of 4.0mmol of aldehyde 89, diluted with 7ml of 
THF dry, was added dropwise. After 2h, reaction was stopped by acidification with 10ml of 
HCl 1.0M; then solution was extracted with diethyl ether/H2O. Ether phase was anidryfied 
on Na2SO4, concentrated in vacuo and purified by silica gel chromatography, eluting with 
petroleum ether/ diethyl ether 99/1. 
Wittig product 92 was obtained in a yield of 60%. 
 
Compound 92 
1H-NMR (CDCl3, 300 MHz): δ  5.33 (2H, m), 4.12 (2H, q, J= 7.1 Hz), 3.58 (2H, t, J= 6.3Hz ), 
2.27 (2H, t, J= 7.6 Hz), 2.00 (4H, m), 1.62 (2H, m), 1.49 (2H, m),  1.36-1.24 (12H, m),0.88 (9H, 


















The removal of protecting group t-BDMSi was directly executed by making, in a plastic 
container, a mixture of 3.0mmol of 92 with 30ml of HF 48%, and 100ml of CH3CN. The 
reaction was monitored and after 3h it was completed. HF was neutralized by adding 
NaHCO3 until the end of effervescence. 
The obtained solution was extracted with ethyl acetate/H2O. Organic phase was anidryfied 
on Na2SO4, concentrated in vacuo and purified by silica gel chromatography, eluiting with 
petroleum ether/ diethyl ether from 85/15 to 7/3. 
Yield of 93 was of 90%. 
 
 
(Z)-Ethyl 16-hydroxyhexadec-7-enoate (93) 
1H-NMR (CDCl3, 400 MHz): δ  5.33 (2H, m), 4.11 (2H, q, J= 7.1 Hz), 3.63 (2H, t, J= 6.6 Hz ), 
2.28 (2H, t, J= 7.6 Hz), 2.00 (4H, m), 1.57 (4H, m), 1.34-1.28 (14H, m),  1.24 (3H, t, J= 7.1 
Hz). 
13C-NMR (100.03 MHz CDCl3): δ  174.1 (s), 130.3 (d ), 129.5(d ),  63.7 (t ), 60.2 (t ),   29.7( t), 
29.5 ( t), 29.4 ( t), 29.3 ( t), 29.2 ( t),  28.8 ( t), 27.2 ( t), 27.0 ( t), 25.7 (t), 24.9 (t), 14.2 (q). 






















A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. Then, 0.04mmol of hydroxy-ester 93 were added to the reaction flask and 
it was immersed in a bath at 40° C for 3h. 
When the reaction finished, the enzyme was removed from the solution by filtration and 
concentrated under vacuum. The crude was purified on silica and eluted with petroleum 
ether/chloroform 8/2. 




1H-NMR (CDCl3, 400 MHz): δ  5.33 (2H, m), 4.13 (2H, m), 2.32 (2H, t, J= 6.64 Hz), 2.03 (4H, 
m), 1.61 (4H, m), 1.38 - 1.25 (14H, m). 
13C-NMR (100MHz CDCl3): δ  174.2 (s), 130.4 (d), 130.2 (d), 63.9(t ), 34.8 (t ), 29.9 ( t), 29.6 
(t), 28.9 ( t), 28.7 (t), 28.6 (t),  28.5 (t), 27.9 (t), 27.2 (t), 27.0 (t), 25.6 (t), 25.5 (t). 
MS (m/z): 252, 104, 96. 





4.4 Synthesis of 15-hexadecanolide   











Alcohol group was protected by reaction with t-BDMS-Cl. 
A solution was prepared by mixing 75mmol of ethyl 3-hydroxy butirrate, 99mmol of  t-
BDMS-Cl, 99mmol of imidazole and 74ml of dichloromethane dry. The reaction goes at room 
temperature, stirring vigorously, in 20h. 
After adding 50ml of H20, mixture was extracted with diethyl ether/H2O. Ethereal phases 
were anhydrified on Na2SO4, concentrated in vacuo, purified by silica gel chromatography, 
and eluted with petroleum ether/ diethyl ether 97/3. 
98% of pure 98 was obtained. 
 
tert-butyl dimethyl silil ethyl butirrate (98) 
1H-NMR (CDCl3, 400 MHz): δ  4.26 (1H, m), 4.08 (2H, m), 2.45 (1H, dd, J= 14.5 and 7.6 Hz), 
2.34 (1H, dd, J= 14.5 and 5.3 Hz), 1.24 (3H, t, J= 7.2), 1.17 (3H, d, J= 6.1),  0.85 (9H, s), 0.06 
(6H, s). 
13C-NMR (62.89 MHz CDCl3): δ  171.8 (s), 66.1 (d), 60.4 (t),  45.2 ( t), 25.9 (q, 3C),  24.1 (t), 
















65mmol of 98 were diluited with 60ml of CH2Cl2 dry. Then, under N2 atmosphere, during 2h, 
at -78°C (CO2/acetone bath), 65mmol of DIBAL-H (1.0M in CH2Cl2) diluted 1/1 with CH2Cl2 
dry, were added to solution. 
At the end, 30ml of a sature solution of Na/K tartrate were added to neutralize DIBAL-H; the 
mixture was extracted with diethyl ether/H2O. Ethereal phases were anhydrified on Na2SO4, 
concentrated in vacuo, purified by silica gel chromatography and eluted with pentane/ diethyl 
ether 99/1. 
Aldehyde 99 was obtained in a yield of 80%. 
 
tert-butyl dimethyl silil butirraldehyde (99) 
1H-NMR (CDCl3, 400 MHz): δ  9.79 (1H, br s), 4.34 (1H, m), 2.54 (2H, ddd, J= 15.7 Hz, J= 
6.9 Hz, J= 2.7 Hz ), 1.23 (3H, d, J= 6.1 Hz),  0.86 (9H, s), 0.07 (3H, s), 0.05 (3H, s). 
13C-NMR (62.89 MHz CDCl3): δ  202.1 (d), 64.4 (d), 52.9 (t), 25.7 (q, 3C),  24.1 (t), 17.8 (q), -
5.4 (q, 2C). 
 









Bromo-ester 95 is prepared by Fisher esterification reaction, performed preparing a solution 
of 4mmol 12-hydroxy dodecanoic acid in 20ml of methanol and acidified with 10 drops of 
sulfuric acid 96%. 
 106 
It leads to reflux at 70° C for 20 hours. After we performed an extraction with diethyl  ether 
and water. Ethereal phases were combined, anhydrified on Na2SO4 and concentrated under 
vacuum. The reaction is almost quantitative, but the ester 17 was purified on silica and eluted 
with petroleum ether/diethyl ether 95/5. 
 
methyl 12-bromo dodecanoate (95)   
1H-NMR (CDCl3, 400 MHz): δ  3.47 (23H, s), 3.23 (1H, t, J= 6.9 Hz), 2.11 (2H, t, J= 7.5 Hz), 
1.67 (2H, m), 1.43 (2H, m), 1.24 (2H, m), 1.11 (12H, m). 
 
 








A mixture containing 3mmol of 95,  3mmol of triphenilphosphine and 10ml of CH3CN was 
placed under reflux, at 90°C for 72h. After the system went at room temperature, solution 
was concentrated in vacuo, purified by silica gel chromatography and eluted with petroleum 
ether/ diethyl ether 97/3. 
Phosphonium salt 96 was obtained in a yield of 90%. 
 
Phosphonium salt of methyl 12 bromo dodecanoate (96)   
1H-NMR (CDCl3, 250 MHz): δ  7.68-7.58 (15H, m), 4.57 (3H, s), 2.17 (2H, t, J= 7.4 Hz), 1.49 





















1.5mmol of 96 were placed in a anhydrified flask and washed 3-4 times with toluene dry. 
Toluene was then removed in vacuo and flask was maintained under N2.  
5ml of THF dry were added to phosphonium salt at 0°C stirring for some minutes. At this 
temperature 1.5mmol of a solution of TMSA-K (0.5M in toluene) were diluted with 5ml of 
THF dry, are added to reaction flask; then the system was maintained at room temperature 
for 30 minutes.  Then, a solution of 1.2mmol of aldehyde 99 diluted with 3ml of THF dry was 
added at 0°C, drowise. After 2h, reaction was stopped by acidification with 2ml of HCl 1.0M; 
than solution was extracted with ethylic ether/H2O. Ether phase was anidryfied on Na2SO4, 
concentrated in vacuo and purified by silica gel chromatography, eluiting with petroleum 
ether/ethylic ether 99/1. 
Wittig product 100 was obtained in a yield of 60%. 
 
Compound 100 
1H-NMR (CDCl3, 250 MHz): δ  5.38 (2H, m), 3.78 (1H, m), 3.65 (3H, s), 2.29 (1H, t, J= 7.4 
Hz), 2.18 (2H, m), 2.06 (2H, m), 1.60 (2H, m), 1.26 (14H, m), 1.11 (1H, d, J= 6.1 Hz),  0.87 






















The removal of protecting group t-BDMSi was directly executed by making, in a plastic 
container, a mixture of 0.6mmol of 100 with 6ml of HF 48%, and 20ml of CH3CN. The 
reaction was monitored and after 3h it was completed. HF was neutralized by adding 
NaHCO3 until the end of effervescence.  
The obtained solution was extracted with ethyl acetate/H2O. Organic phase was anhydrified 
on Na2SO4, concentrated in vacuo, purified by silica gel chromatography and elute with 
petroleum ether/ethylic ether from 85/15 to 7/3. 
Yield of 101 was of 90%. 
 
(Z)-methyl 15-hydroxyhexadec-12-enoate (101) 
1H-NMR (CDCl3, 250 MHz): δ  5.49 (1H, m), 5.34 (1H, m), 3.77 (1H, m), 3.62 (3H, s), 2.26 
(1H, t, J= 7.5 Hz), 2.18-2.10 (2H, m), 2.00 (2H, m), 1.60 (2H, m), 1.22 (14H, m), 1.15 (1H, d, 
































A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of hydroxy-ester 20 was added to the reaction 
flask and it was immersed in a bath at 40° C for 1h. 
After the reaction, the enzyme was removed from the solution by filtration and concentrated 
under vacuum. The crude was purified on silica and eluted with Petroleum ether/diethyl 
ether from 95/5 to 8/2. 
41 % of 102 was obtained together with unreacted alcohol.   
 
Compound 102 
1H-NMR (CDCl3, 400 MHz): δ  5.50 (1H, m), 5.34 (1H, m), 4.94 (1H, m),  2.46 (1H, m), 2.22-
1.96 (4H, m), 1.63 (2H, m), 1.32 (14H, m). 1.26 (3H, d). 
ES-MS (m/z)= 256 (M+).  
 
In order to investigate on the enantiomeric purity of the recovered unreacted alcohol, Mosher 
esters were prepared following a described procedure starting from (R)- MTPA-Cl.241   
Chromatographic analysis by HPLC (ODH chiral column, hexane-isopropanol 97/3 at 1.0 
ml/min and refrective index as detector) of Mosher ester derivatives  of  racemic and  
























































The double bond of 102  was satured by catalytic hydrogenation to give 103.  
0.016mmol of 102 was anhydrified (vacuum/N2) in a flask and diluited with 1ml of ethanol. 
Than a little quantity of Pd/C (spatula tip) was added and manteined under pressure of 
hydrogen for 1 hour and stirred vigorously. At the end of time, the crude of reaction was 
filtered on stopper of celite, and washed with chloroform. The solution was concentrated in 
vacuo, purified by silica gel chromatography and eluted with Petroleum ether/diethyl ether 
95/5. 
Was recovered 90 % of 103   
 
15-methyl pentadecanolide (103) 
1H-NMR (CDCl3, 400 MHz): δ  4.93-4.99 (1H, m), 2.32 (1H, ddd, J= 6.3 Hz, J= 8.3 Hz,  J= 
14.5 Hz), 2.28 (1H, ddd, J= 6.1 Hz, J= 6.8 Hz,  J= 14.5 Hz), 1.67-1.76 (1H, m), 1.47-1.63 (1H, 
m), 1.25-1.42 (20H, m). 
13C-NMR (100MHz CDCl3): δ  171.6 (s), 71.5 (d), 34.9 (t), 34.4 (t), 24.8 (t), 21.0-27.3 (t), 21.7 
(t). 
ES-MS (m/z)= 254 (M+).  
IR (cm-1): 2930, 2860, 1735, 1460, 1375,  














A solution was prepared by mixing 7.5mmol of ethyl 3-(R)-hydroxy butirrate, 9.9mmol of  t-
BDMS-Cl, 9.9mmol of imidazole and 8ml of dichloromethane dry. The reaction goes at room 
temperature, stirring vigorously, in 20h. 
After adding 50ml of H20, mixture was extracted with diethyl ether/H2O. Ethereal phase was 
anhydrified on Na2SO4, concentrated in vacuo, purified by silica gel chromatography and 
eluted with petroleum ether/ethylic ether 97/3. 
98% of pure (R)-98 is obtained. 
 
 








6.5mmol of (R)-98 were diluted with 6.0ml of CH2Cl2 dry. Then, under N2 atmosphere, during 
2h, at -78°C (CO2/acetone bath), 6.5mmol of DIBAL-H (1.0M in CH2Cl2) diluted 1/1 with 
CH2Cl2 dry, were added to solution. 
After the time passed, 3.0ml of a sature solution of Na/K tartrate were added to neutralize 
DIBAL-H; the mixture was extracted with ethylic ether/H2O. Ethereal phase was anhydrified 
 113 
on Na2SO4, concentrated in vacuo, purified by silica gel chromatography, and eluted with 
pentane/ethylic ether 99/1. Aldehyde (R)-99  was obtained in a yield of 80%. 
 
 









1.5mmol of 96 were introduced in a anhydrified flask and washed 3-4 times with toluene dry. 
Toluene was then removed in vacuo and flask was maintained under N2. 5ml of THF dry 
were added to phosphonium salt at 0°C stirring for some minutes. At this temperature 
1.5mmol of a solution of TMSA-K (0.5M in toluene) were diluted with 5ml of THF dry, are 
added to reaction flask; then the system was maintained at room temperature for 30 minutes. 
After this time was passed, we returned system at 0°C and added, drop to drop, a solution of 
1.0mmol of aldehyde (R)-99  diluted with 3ml of THF dry. After 2h, reaction was stopped by 
acidification with 2ml of HCl 1.0M; than solution was extracted with diethyl ether/H2O. After 
purification, Wittig product  was obtained. 
t-BDMSi was removed by making, in a plastic container, a mixture of 0.6mmol of Wittig 
product with 6ml of HF 48%, and 20ml of CH3CN. The reaction was monitored and after 3h it 
was completed. HF was neutralized by adding NaHCO3 until the end of effervescence. The 
obtained solution was extracted with ethyl acetate/H2O. Organic phase was anhydrified on 
Na2SO4, concentrated in vacuo, purified by silica gel chromatography and eluted with 
petroleum ether/diethyl ether from 85/15 to 7/3. 





















A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of hydroxy-ester (R) 101 was added to the 
reaction flask and it was immersed in a bath at 40° C for 1h. 
After the reaction, the enzyme was removed from the solution by filtration and concentrated 
under vacuum. The crude was purified on silica and eluted with Petroleum ether/diethyl 
ether from 95/5 to 8/2. 80 % of 102 was obtained.   
 
 
15 (R) hexadecenolide (102) 
 
1H-NMR (CDCl3, 400 MHz): δ  5.50 (1H, m), 5.34 (1H, m), 4.94 (1H, m),  2.46 (1H, m), 2.22-
1.96 (4H, m), 1.63 (2H, m), 1.32 (14H, m). 1.26 (3H, d). 
























The double bond of 102  was satured by catalytic hydrogenation to give 103.  
0.016mmol of 102 was anhydrified (vacuum/N2) in a flask and diluited with 1ml of ethanol. 
Than a little quantity of Pd/C (spatula tip) was added and manteined under pressure of 
hydrogen for 1 hour and stirred vigorously. At the end of time, the crude of reaction was 
filtered on stopper of celite, and washed with chloroform. The solution was concentrated in 
vacuo, purified by silica gel chromatography and eluted with Petroleum ether/diethyl ether 
95/5. 
Was recovered 90 % of 103.   
 
(R) hexadecanolide (103) 
1H-NMR (CDCl3, 400 MHz): δ  4.93-4.99 (1H, m), 2.32 (1H, ddd, J= 6.3 Hz, J= 8.3 Hz,  J= 
14.5 Hz), 2.28 (1H, ddd, J= 6.1 Hz, J= 6.8 Hz,  J= 14.5 Hz), 1.67-1.76 (1H, m), 1.47-1.63 (1H, 
m), 1.25-1.42 (20H, m), 1.22 (30H, d, J= 6.3 Hz). 
13C-NMR (100MHz CDCl3): δ  171.6 (s), 71.5 (d), 34.9 (t), 34.4 (t), 24.8 (t), 21.0-27.3 (t), 21.7 
(t). 
MS (m/z)= 254 (M+).  
IR (cm-1): 2930, 2860, 1735, 1460, 1375, 1340, 1260, 1205, 1180, 1130, 1110, 790 















Alcohol group was protected by reaction with t-BDMS-Cl. 
A solution was prepared by mixing 7.5mmol of ethyl 3-(R)-hydroxy butirrate, 9.9mmol of  t-
BDMS-Cl, 9.9mmol of imidazole and 8ml of dichloromethane dry. The reaction goes at room 
temperature, stirring vigorously, in 20h. 
After adding 50ml of H20, mixture was extracted with diethyl ether/H2O. Ethereal phase was 
anhydrified on Na2SO4, concentrated in vacuo, purified by silica gel chromatography and 
eluted with petroleum ether/ethylic ether 97/3. 
98% of pure (S)-98 is obtained. 
 








6.5mmol of (S)-98 were diluted with 6.0ml of CH2Cl2 dry. Then, under N2 atmosphere, during 
2h, at -78°C (CO2/acetone bath), 6.5mmol of DIBAL-H (1.0M in CH2Cl2) diluted 1/1 with 
CH2Cl2 dry, were added to solution. 
After the time passed, 3.0ml of a sature solution of Na/K tartrate were added to neutralize 
DIBAL-H; the mixture was extracted with ethylic ethr/H2O. Ethereal phase was anhydrified 
 117 
on Na2SO4, concentrated in vacuo, purified by silica gel chromatography, and eluted with 
pentane/ethylic ether 99/1. 
Aldehyde (S)-99  was obtained in a yield of 80%. 
 
 










1.5mmol of 96 were introduced in a anhydrified flask and washed 3-4 times with toluene dry. 
Toluene was then removed in vacuo and flask was maintained under N2. 5ml of THF dry 
were added to phosphonium salt at 0°C stirring for some minutes. At this temperature 
1.5mmol of a solution of TMSA-K (0.5M in toluene) were diluted with 5ml of THF dry, are 
added to reaction flask; then the system was maintained at room temperature for 30 minutes. 
After this time was passed, we returned system at 0°C and added, drop to drop, a solution of 
1.0mmol of aldehyde (S)-99  diluted with 3ml of THF dry. After 2h, reaction was stopped by 
acidification with 2ml of HCl 1.0M; than solution was extracted with diethyl ether/H2O. After 
purification, Wittig product was obtained. 
t-BDMSi was removed by making, in a plastic container, a mixture of 0.6mmol of Wittig 
product with 6ml of HF 48%, and 20ml of CH3CN. The reaction was monitored and after 3h it 
was completed. HF was neutralized by adding NaHCO3 until the end of effervescence. The 
obtained solution was extracted with ethyl acetate/H2O. Organic phase was anhydrified on 
Na2SO4, concentrated in vacuo, purified by silica gel chromatography and eluted with 
petroleum ether/diethyl ether from 85/15 to 7/3. 




















A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of hydroxy-ester (S)-101  was added to the 

















4.5 Synthesis of 15-octadec-12-enolide 









Alcohol group was protected by reaction with t-BDMS-Cl. 
A solution was prepared by mixing 13mmol of methyl 3 hydroxy hexanoate, 16mmol of  t-
BDMS-Cl, 16mmol of imidazole and 14ml of dichloromethane dry. The reaction goes at room 
temperature, stirring vigorously, in 20h. 
After adding 50ml of H20, mixture was extracted with diethyl ether/H2O. Ether phase was 
anhydrified on Na2SO4, concentrated in vacuo, purified by silica gel chromatography and 
eluted with hexane/diethyl ether 95/5. 
90% of pure 108 is obtained. 
 
t-butyl dimethyl silil ethyl hexanoate (108)  
1H-NMR (CDCl3, 400 MHz): δ  4.12 (1H, m), 3.65 (3H, m), 2.43 (2H, dd, J= 1.9 and 6.8 Hz), 
1.48-1.36 (2H, m), 1.34-1.26 (2H, m),  0.92 (3H, t), 0.87 (9H, s), 0.03 (6H, s). 
13C-NMR (62.89 MHz CDCl3): δ  173.2 (s), 69.2 (d), 51.3 (t), 42.4 (t),  39.7 (t), 25.5 (q, 3C), 

















6.1mmol of 108 were diluted with 6ml of CH2Cl2 dry. Then, under N2 atmosphere, during 2h, 
at -78°C (CO2/acetone bath), 6.1mmol of DIBAL-H (1.0M in CH2Cl2) diluted 1/1 with CH2Cl2 
dry, were added to solution. 
Subsequently, 3ml of a sature solution of Na/K tartrate were added to neutralize DIBAL-H; 
the mixture was extracted with diethyl ether/H2O. Ether phase was anhydrified on Na2SO4, 
concentrated in vacuo, purified by silica gel chromatography and elute with petroleum 
ether/diethyl ether 99/1. 
Aldehyde 109 was obtained in a yield of 80%. 
 
 
t-butyl dimethyl silil butirraldehyde  (109) 
1H-NMR (CDCl3, 400 MHz): δ  9.79 (1H, br s), 4.16 (1H, m), 3.45 (2H, m), 2.48 (2H, m), 1.25 
(2H, m), 1.18 (3H, d, J= 6.1 Hz),  0.86 (9H, s), 0.07 (3H, s). 
13C-NMR (62.89 MHz CDCl3): δ  203.6 (d), 69.3 (d), 52.0 (t), 41.3 (t), 26.79 (q, 3C),  19.6 (t), 





















4.4mmol of 106 were placed in a anhydrified flask and washed 3-4 times with toluene dry. 
Toluene was then removed in vacuo and flask was maintained under N2.  
15ml of THF dry were added to phosphonium salt at 0°C stirring for some minutes. At this 
temperature 4.4mmol of a solution of TMSA-K (0.5M in toluene) were diluted with 10ml of 
THF dry, are added to reaction flask; then the system was maintained at room temperature 
for 30 minutes.  
Then, a solution of 4.1mmol of aldehyde 109 diluted with 10ml of THF dry was added, 
dropwise at 0°C. After 2h, reaction was stopped by acidification with 10ml of HCl 1.0M; than 
solution was extracted with diethyl ether/H2O. Ether phase was anhyidrified on Na2SO4, 
concentrated in vacuo, purified by silica gel chromatography and eluted with petroleum 
ether/diethyl ether 99/1. 





1H-NMR (CDCl3, 400 MHz): δ  5.47 (1H, m), δ  5.35 (1H, m), 3.61 (3H, s), 2.25 (2H, t, J= 7.6 















The removal of protecting group t-BDMSi was directly executed by making, in a plastic 
container, a mixture of 1.2mmol of 110 with 12ml of HF 48%, and 40ml of CH3CN. The 
reaction was monitored and after 3h it was completed. HF was neutralized by adding 
NaHCO3 until the end of effervescence. 
The obtained solution was extracted with ethyl acetate/H2O. Organic phase was anhydrified 
on Na2SO4, concentrated in vacuo, purified by silica gel chromatography and elute with 
petroleum ether/diethyl ether from 95/5 to 8/2. 
Yield of 111 was of 90%. 
 
(Z)-methyl 15-hydroxyocta dec-12-enoate (111). 
 
1H-NMR (CDCl3, 400 MHz): δ  5.47 (1H, m), δ  5.35 (1H, m), 3.62 (3H, s), 2.25 (2H, t, J= 7.6 































A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of hydroxy-ester 111 was added to the reaction 
flask and it was immersed in a bath at 65° C for 24h. 
After the reaction, the enzyme was removed from the solution by filtration and concentrated 
under vacuum. The crude was purified on silica and eluted with hexane/diethyl ether from 
95/5 to 1/1. 
28 % of 112 was obtained.   
 
15-octadec-12-enolide (112) 
1H-NMR (CDCl3, 400 MHz): δ  5.51 (1H, m), 5.36 (1H, m), 4.95 (1H, m),  2.38 (2H, m), 2.30-
2.22 (4H, m), 2.02 (2H, m), 1.59 (2H, m), 1.55 (2H, m), 1.37 (14H, t), 0.91 (3H, t, J= 7.3 Hz ). 
13C-NMR (100MHz CDCl3): δ  132.7 (s), 124.52 (d), 73.4 (d), 35.7 (t), 32.3 (t),  34.3 (t), 32.5 
(t),  27.7 (t), 26.6 (t), 26.5 (t), 26.3 (t), 26.2 (t), 26.1 (t), 26.0 (t), 25.8 (t), 24.4 (t), 18.4 (t), 13.7 
(q). 







4.6 Synthesis of aplyiolides B and D 














A mixture is prepared with 33.5mmol cesium carbonate, 33.5mmol of sodium iodide, 33.5mol 
of cuprous iodide, 60ml of N,N-dimethylformamide, 33.5mmol of propargyl alcohol and 
33.5mmol of (E) -1 -bromo-pent-2-ene. 
After 20 hours, we added a saturated aqueous solution of ammonium chloride and we 
extracted with diethyl ether. The combined organic phases were anhydrified on Na2SO4 and 
concentrated under vacuum. The crude was purified rapidly by DMF on silica gel with 
petroleum ether. Alcohol mixture of the two isomers, 113 and 113*, was diluted with 
anhydrous CH2Cl2; after 55mmol of carbon tetrabromide were added to it. To this solution at 
a temperature of 0° C was added dropwise a solution consisting of 55mmol of 
triphenylphosphine in dichloromethane. We kept stirring and monitoring by TLC; then we 
pulled 90% of dry CH2Cl2, obtaining a dense mixture that was loaded on silica. Then we 
eluted with petroleum ether rapidly achieving the blend of only the bromides 114 and 114*.  
20ml of t-butanol, 20ml of water and 5.0g of AD-mix-α™ were placed in a flask. The 
agitation at room temperature forms a biphasic system of light colored; so we added the 
3.6mmol of metansulfonammide. The mixture was cooled to 0° C to dissolve precipitated 
salts. Then the mixture of olefins were slowly added and left stirring for 20 hours at 0° C, 
monitoring the course of the reaction by TLC. While mixture was still at 0° C, 2.5g of 
Na2SO3 were added, the reactor was brought to room temperature, stirring for 1 hour. Ethyl 
acetate was added and the aqueous phase was extracted, anhydrified and purified on flash 
silica eluting with acetate / hexane.  Product 115 was obtained with a total yield of 60% in 






1H-NMR (CDCl3, 400 MHz): δ  3.92 (2H, t), 3.65 (1H, dddd, J= 6.4 Hz, J= 5.9 Hz,  J= 4.7 
Hz, J= 5.7 Hz), 3.52 (1H, ddd, J= 4.8 Hz, J= 4.7 Hz,  J= 5.6 Hz), 2.50-2.56 (2H, ddt, J= 5.9 
Hz, J= 2.2 Hz,  J= 17.0 Hz), 2.28 (1H, d, J= 5.7 Hz), 1.99 (1H, d, J= 5.6 Hz), 1.60 (1H, ddq, 
J= 4.8 Hz, J= 7.4 Hz, J= 14.2 Hz), 1.51 (1H, dq, J= 7.4 Hz, J= 14.2 Hz), 1.00 (1H, t, J= 7.4 
Hz). 










46ml of DAP were added to 34mmol of NaH. The mixture was stirred at 80° C. There was 
evolution of hydrogen and one hour after the solution became clear dark for the formation of 
aminopropilammid. At room temperature we added a solution of 4.2mmol 3-Decin-1-ol in 
16ml of DAP and left overnight at 70° C. After cooling, water was added and extracted 
several times with diethyl ether. The combined ethereal phases were washed with water, 
diluted HCl and a solution of NaCl, then anhydrified on Na2SO4. Filtration and subsequent 
concentration leaded to 4mmol of 116 already pure. The yield is 95%. 
 
9 decyn-1-ol (116) 
1H-NMR (CDCl3, 400 MHz): δ  3.64 (2H, t, J= 6.3 Hz), 2.18 (2H, dt, J= 7.2 Hz, J= 2.7 Hz), 
2.94 (1H, t, J= 2.7 Hz), 1.54 (4H, m), 1.42-1.30 (8H, m). 




4.6.3 Synthesis of 9 decynoic acid (117) 




9-decinoic acid was obtained by oxidation of alcohol function of 116 with Jones reagent. This 
was prepared dissolving from 2.14g of CrO3 in 6.2ml of water which were added, at 0° C, 
1.84ml of concentrated H2SO4. It was left to stir for 1 h, then diluted with 60ml of acetone. 
8mmol of alcohol were diluted in acetone (60ml) and, at 0°C, Jones reagent was added 
dropwise over 4 hours. Green color of solution showed Cr (III); color turned red in the first 
excess of Cr (VI). Addition of the oxidizer was suspended to the first red finish.  
Isopropanol was added slowly to reduce the excess of Cr (VI) until the solution turns green; 
the resulting mixture was filtered on Celite and washed with acetone. Solution was 
concentrated and diluted with dichloromethane, extracted the carboxylate with a solution in 
1M NaOH. Then solution was acidified with 8-9ml of concentrated sulfuric acid to pH 1-2 
and extracted with dichloromethane. At the end, solution was anhydrified on Na2SO4 and 
concentrated. It is not necessary purification: yield 95%.  
 
9 decynoic acid (117) 
1H-NMR (CDCl3, 400 MHz): δ  2.34 (2H, t, J= 7.4 Hz), 2.18 (2H, dt, J= 7.2 Hz, J= 2.7 Hz), 
1.93 (1H, t, J= 2.7 Hz), 1.62 (2H, tt, J= 7.4 Hz, J= 7.2 Hz), 1.50 (2H, tt, J= 7.5 Hz, J= 7.2 
Hz) 1.44-1.29 (6H, m). 












To a solution consisting of 3.8mmol of 9-decinoic acid 117 and 20ml methanol were added a 
few drops of sulfuric acid 96%. After 15 hours reflux at 80° C, the reaction mixture is 
extracted with pentane and the combined organic phases were anhydrified on sodium sulfate 
and concentrated under vacuum. The yield is quantitative. 
 
Methyl 9-decynoate (118) 
1H-NMR (CDCl3, 400 MHz): δ  3.66 (3H, s), 2.28 (2H, t, J= 7.5 Hz), 2.17 (2H, dt, J= 7.1 Hz, 
J= 2.7 Hz), 1.60 (2H, tt, J= 7.5 Hz, J= 7.2 Hz), 1.48 (2H, tt, J= 7.4 Hz, J= 7.1 Hz) 1.44-1.29 
(6H, m). 
13C-NMR (100MHz CDCl3): δ  174.0 (s), 84.4 (s), 68.0(t), 51.2 (q), 33.8 (t), 28.2-28.8 (t), 24.7 
(t), 18.2 (t). 












To a suspension consisting of 3.6mmol of cesium carbonate, 3.6mmol sodium iodide, cuprous 
iodide 3.6mmol in 10ml of DMF, were added 3.6mmol of 118, then 3.6mmol of 115, leaving 
under stirring for 20 hours. After adding a saturated solution of ammonium chloride, it was 
extracted with diethyl ether, anhydrified and concentrated under vacuum. The crude was 
purified on silica gel, eluenting with petroleum ether / diethyl ether (from 9 / 1 to 1 / 1). 
3mmol of 119 are obtained (85%). 
 
Methyl 15(S),16(S)-dihydroxy-octadeca-9,12-dynoate (119) 
1H-NMR (CDCl3, 400 MHz): δ  3.66 (3H, s), 3.60 (1H, ddd, J= 4.3 Hz, J= 5.3 Hz, J= 6.4 Hz), 
3.50 (1H, ddd, J= 4.3 Hz, J= 8.3 Hz, J= 4.6 Hz), 3.12 (2H, tt, J= 2.3 Hz, J= 2.3 Hz) 2.41-2-46 
(2H, ddt, J= 2.3 Hz, J= 5.3 Hz, J= 6.4 Hz, J= 16.7 Hz), 2.30 (2H, t, J= 7.5 Hz), 2.13 (2H, tt, 
J= 7.0 Hz, J= 2.3 Hz), 1.62 (2H, bt, J= 7.5 Hz), 1.52-1.58 (2H, ddq, J= 7.4 Hz, J= 8.3 Hz, J= 
4.6 Hz, J= 14.1 Hz), 1.47 (2H, bt, J= 7.0 Hz), 1.40-1.24 (6H, m), 0.98 (3H, bt, J= 7.4 Hz). 
13C-NMR (100MHz CDCl3): δ  174.4 (s), 74.5 (d), 74.0-80.8 (s), 71.9 (d), 51.4 (s), 34.0 (t), 
28.5-29.0 (t), 26.4 (t), 24.8 (t), 24.4 (t), 18.6 (t), 10.0 (t), 9.7 (t). 
MS (m/z): 323 (M+) 





























To a solution of 2.6mmol of 119 in 10ml of methanol was added a catalytic amount of Lindlar 
and a few drops of quinoline. We left react under mild hydrogen pressure for a night: the 
reaction monitored by TLC, was practically quantitative. It was purified on silica only to 
remove the quinoline and the catalyst, eluting with hexane / ethyl acetate 8:2.  
 
Methyl 15(S),16(S)-dihydroxyoctadeca-9(Z),12(Z)-dyenoate (120) 
1H-NMR (CDCl3, 400 MHz): δ  5.54 (1H, bdt, J= 10.7 Hz, J= 6.6 Hz), δ  5.40 (1H, dt, J= 
10.7 Hz, J= 6.0 Hz),   5.35 (1H, bdt, J= 10.7 Hz, J= 6.5 Hz),  3.66 (3H, s), 3.51 (1H, dt, J= 4.9 
Hz, J= 6.8 Hz), 3.40 (1H, ddd, J= 8.8 Hz, J= 8.3 Hz, J= 4.9 Hz),  2.81 (2H, dd, J= 6.6 Hz, J= 
6.5 Hz) 2.33 (2H, bdd, J= 7.5 Hz, J= 6.8 Hz), 2.30 (2H, t, J= 7.5 Hz), 2.06 (2H, bdt, J= 6.0 
Hz, J= 6.7 Hz), 1.62 (2H, bt, J= 7.5 Hz), 1.61 (1H, m), 1.51 (1H, ddq, J= 8.3 Hz, J= 7.5 Hz, 
J= 15.0 Hz), 1.36-1.28 (8H, m), 0.99 (3H, t, J= 7.5 Hz). 
13C-NMR (100MHz CDCl3): δ  174.4 (s), 131.6 (t), 130.6 (d), 127.3 (d), 125.1 (d), 75.2 (d),  
73.4 (d), 71.9 (t),  51.5 (q), 34.1 (t), 31.8 (t), 29.1-29.5 (t), 26.5 (t), 25.8 (d), 24.9 (t), 10.0 (q). 
MS (m/z): 326 (M+) 



















Aplyolide B (26) Aplyolide D (27)  
  
A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of dihydroxy-ester 120 was added to the reaction 
flask and it was immersed in a bath at 40° C until 48h. 
After the reaction, the enzyme was removed from the solution by filtration and concentrated 
under vacuum. The crude was purified on silica and eluted with hexane / chloroform 6 / 4. 
The total yield is of 37% of 27 (with traces of 26). 
 
 
Aplyolide D (27) 
1H-NMR (CDCl3, 400 MHz): δ  5.51 (1H, m), δ  5.38 (1H, m),   4.96 (1H, m),  3.57 (1H, m), 
2.90-2.76 (2H, m), 2.51-2.43 (2H, m),  2.38-2.31 (2H, ddd, J= 15.9 Hz, J= 9.0 Hz, J= 4.1 Hz),  
2.15-1.95 (2H, m), 1.73-1.62 (2H, m), 1.50 (2H, m), 1.34 (8H, m), 0.99 (3H, t, J= 7.5 Hz). 
13C-NMR (100MHz CDCl3): δ  173.4 (s), 131.8 (d), 129.9-127.6 (d), 124.6 (d), 75.4 (d),  73.6 
(d), 34.1 (t), 33.8 (t), 28.0-27.1 (t), 26.9 (t), 25.9 (t), 25.7 (t), 24.5 (t), 10.0 (q). 
MS (m/z): 294 (M+) 
IR (cm-1): 1730 






4.7 Synthesis of enantiomers of aplyolides B and D 
Enantiomers of aplyolides B and D were prepared following a similar synthetic scheme but 
using AD-mix-β™ for the Sharpless asymmetric dihydroxylation. At the end, obtained methyl 





















A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of dihydroxy-ester 123 was added to the 
reaction flask and it was immersed in a bath at 40° C for 3h. 
After the reaction, the enzyme was removed from the solution by filtration and concentrated 
under vacuum. The crude was purified on silica and eluted with hexane / chloroform 6 / 4. 
Enantiomer of aplyolide B (124) was obtained in yield of 81%.  
 132 
 
Enantiomer of aplyolide B (124) 
1H-NMR (CDCl3, 400 MHz): δ  5.62 (1H, m), 5.41 (1H, m), 5.37 (2H, m),  4.83 (1H, m),  3.71 
(1H, m), 2.85-2.78 (2H, ddd, J= 16.0 Hz, J= 7.0 Hz, J= 7.0 Hz), 2.47-2.38 (2H, ddd, J= 15.3 
Hz, J= 4.9 Hz, J= 7.0 Hz),  2.31-2.18 (2H, ddd, J= 14.7 Hz, J= 9.0 Hz, J= 9.0 Hz),  2.04-1.97 
(2H, m), 1.77-1.65 (2H, m), 1.76 (2H, m), 1.37 (8H, m), 0.92 (3H, t, J= 7.5 Hz). 
13C-NMR (100MHz CDCl3): δ  173.4 (s), 131.8 (d), 130.4 (d), 127.7 (d), 124.9 (d), 76.7 (t),  
71.3 (d), 34.1 (t), 32.5 (t), 28.0-27.3 (t), 26.2 (t), 26.0 (t), 24.9 (t), 20.4 (t), 10.0 (q). 
MS (m/z): 294 (M+) 
IR (cm-1): 1720 
[ ] =24Dα + 16.0 ± 0.1  (c=0.8 in CHCl3) 
 133 
4.8 Synthesis of aplyiolides C and E 






It was prepared a mixture of 33.6mmol of cesium carbonate, 33.6mmol of sodium iodide, 
33.6mmol cuprous iodide and 70ml of N, N-dimethylformamide; to this were added 33.6mmol 
of trimethylsilyl-acetylene and 33.6mmol of (E)-1-bromo-pent-2-ene. A saturated aqueous 
solution of ammonium chloride was added after 20 hours. At the end, it was extracted with 
diethyl ether. The combined organic phases were anhydrified on sodium sulphate, concentrated 
and purified on silica gel eluting with petroleum eth r / diethyl ether (95 / 5). It was obtained 
17mmol of 128 (yield ~ 60%) mixed with 128* (~ 30%), in turn 1:1 enantiomeric mixture. 
Isomers are not separable: their relationship were d ived by integration of NMR signals. 
 
4(E)-epten-1-ynil-trimethylsilane (128) 
1H-NMR (CDCl3, 400 MHz): δ  5.71 (1H, ddt, J= 15.2 Hz, J= 6.4 Hz, J= 1.7 Hz), 5.38 (1H, 
ddt, J= 15.2 Hz, J= 5.7 Hz, J= 1.7 Hz), 2.95 (2H, ddt, J= 1.2 Hz, J= 5.7 Hz, J= 1.7 Hz),  2.04 
(2H, bdt, J= 1.2 Hz, J= 6.4 Hz, J= 1.7 Hz, J= 7.5 Hz),  0.99 (3H, t, J= 7.5 Hz), 0.16 (9H, s). 
13C-NMR (100MHz CDCl3): δ  133.7 (s), 122.6 (d), 104.5 (q), 85.8 (t),  25.2 (d), 21.5 (d), 13.4 













1H-NMR (CDCl3, 400 MHz): δ  5.75 (1H, ddd, J= 17.1 Hz, J= 10.0 Hz, J= 6.0 Hz), 5.29 (1H, 
ddd, J= 17.1 Hz, J= 1.6 Hz, J= 1.3 Hz), 5.08 (1H, ddd, J= 1.3 Hz, J= 10.0 Hz, J= 1.3 Hz),  
3.02 (1H, bddd, J= 7.5 Hz, J= 1.6 Hz, J= 6.0 Hz, J= 1.3 Hz), 1.61 (1H, ddq, J= 7.5 Hz, J= 7.4 
Hz, J= 13.0 Hz), 1.55 (1H, ddq, J= 7.4 Hz, J= 13.3 Hz, J= 6.0 Hz), 0.98 (3H, t, J= 7.4 Hz), 
0.13 (9H, s). 
13C-NMR (100MHz CDCl3): δ  137.4 (d), 115.1 (d), 107.1 (s), 87.0 (s),  37.9 (d), 28.3 (d), 11.1 













































18ml of t-butanol, 18ml of water and 5.0g of AD-mix-α™ were placed into a flask. The 
agitation at room temperature forms a biphasic system of light colored; so we added the 
5mmol of metansulfonammide. The mixture was cooled to 0° C to dissolve precipitated salts. 
Then the mixture of olefins were slowly added and left stirring for 20 hours at 0° C, 
monitoring the course of the reaction by TLC. While mixture was still at 0° C, 7.5g of 
Na2SO3 were added, the reactor was brought to room temperature, stirring for 1 hour. Ethyl 
acetate was added and the aqueous phase was extracted, anhydrified and purified on flash 
silica eluting with acetate / hexane 4/6.  Product 129 was obtained with a yield of 95% (~ 
60% from bromopentene). The diol is a solid stable, white and low melting point.  
 
7-trimethylsilanil-3(S)-4(S)dihydroxy-6-eptyn (129) 
1H-NMR (CDCl3, 400 MHz): δ  3.60 (1H, ddd, J= 5.7 Hz, J= 6.4 Hz, J= 4.5 Hz), 3.48 (1H, 
ddd, J= 4.8 Hz, J= 8.3 Hz, J= 4.5 Hz), 2.49 (1H, dd, J= 5.7 Hz, J= 17.5 Hz),  2.46 (1H, dd, J= 
6.4 Hz, J= 17.5 Hz),  1.55 (1H, ddq, J= 4.8 Hz, J= 7.4 Hz,  J= 21.5 Hz), 1.50 (1H, ddq, J= 8.3 
Hz, J= 7.4 Hz,  J= 21.5 Hz),  0.96 (3H, t, J= 7.5 Hz), 0.13 (9H, s). 
13C-NMR (100MHz CDCl3): δ  103.1 (s), 87.0 (s),  74.3 (d), 71.6 (d),  26.2 (t), 25.3 (t), 9.9 (q), 
0.13 (q). 


















To a solution prepared with 6.4mmol of 129 in 10ml of THF dry were slowly added 8mmol 
of TBAF. Deprotection was monitored by TLC: it was over in an hour. After we added ethyl 
acetate, we extracted several times with water until elimination of fluoride salts. 




1H-NMR (CDCl3, 400 MHz): δ  3.65 (1H, ddd, J= 5.7 Hz, J= 5.6 Hz, J= 4.2 Hz), 3.58 (1H, 
ddd, J= 4.7 Hz, J= 8.2 Hz, J= 4.2 Hz), 2.50 (1H, ddd, J= 5.5 Hz, J= 2.7 Hz, J= 17.0 Hz),  
2.46 (1H, ddd, J= 6.5 Hz, J= 2.7 Hz, J= 17.0 Hz),  1.59 (1H, ddq, J= 7.5 Hz, J= 4.7 Hz,  J= 
14.8 Hz), 1.52 (1H, ddq, J= 8.2 Hz, J= 7.5 Hz,  J= 14.8 Hz),  1.00 (3H, t, J= 7.5 Hz). 
13C-NMR (100MHz CDCl3): δ  80.7 (s),  74.3 (d), 71.6 (d),  70.6 (d),  26.2 (t), 23.9 (t), 9.9 (q). 
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To a solution consisting of 5g of 6-eptinoic acid and 25ml of methanol was added dropwise 1 
ml of sulfuric acid 96%. 
After 15 hours reflux at 80° C, methanol was removed under vacuum and an extraction with 
pentane was performed; the combined organic phases were anhydrified on sodium sulphate and 
concentrated under vacuum. 132 was obtained in yield of 100%. The ester wss present d as a 
yellow liquid, stable over time. 
 
methyl 6-eptynoate (132) 
1H-NMR (CDCl3, 400 MHz): δ  3.67 (3H, s), 2.34 (2H, t, J= 7.5 Hz),  2.20 (2H, dt, J= 7.0 Hz, 
J= 2.4 Hz),  1.95 (1H, t), 1.75 (2H, m), 1.56 (2H, m). 
13C-NMR (100MHz CDCl3): δ  171.3 (s),  83.5 (s), 68.4 (d),  51.1 (q),  33.1 (t), 27.6 (t), 23.6 (t),  











To a suspension consisting of 10mmol of cesium carbonate, 10mmol of sodium iodide, 
10mmol of cuprous iodide and 20ml of N, N-dimethylformamide (DMF) in a nitrogen 
atmosphere at room temperature, were added 10mmol of 132 and 10mmol of 4-chloro-2-
butin-1-ol. After 20 hours a saturated aqueous solution of ammonium chloride was added and 
it was extracted with diethyl ether. The combined organic phases were anhydrified on sodium 
sulfate and concentrated under vacuum. The crude reaction was rapidly purified on silica gel 
with an eluent consisting of a mixture of ethyl ether / petroleum ether 1/1. 
Then, 9.0mmol of obtained compound and 15.3mmol of carbon tetrabromide were diluted 
with 35ml of anhydrous dichloromethane; a solution composed of 15.2mmol of 
triphenylphosphine in 30ml of dichloromethane was added dropwise at 0° C. After a few 
minutes, at the first excess of PPh3, the reaction mixture turns from yellow to brown. It was 
held under agitation for 30-60min, then it was concentrated, obtaining a dense mixture that 
was purified on silica, eluting  8/2 mixture of pentane and diethyl ether. Usually you can 
separate the CHBr3 early fractions (and UV-visible) phosphine salts, insoluble in the eluent 
mixture, remaining on the column. Compound 133 was synthesized in a yield of 85%. 
Bromide obtained was a rather thick orange oil; it tended to decompose more slowly than 
starting alcohol if stored under nitrogen in ether solution. 
 
Methyl 11-bromo-undeca-6,9-dynoate (133) 
1H-NMR (CDCl3, 400 MHz): δ  3.93 (2H, t, J= 2.3 Hz), 3.67 (3H, s), 3.21 (2H, tt, J= 2.3 Hz),  
2.34 (2H, t, J= 7.3 Hz),  2.19 (2H, tt, J= 7.1 Hz, J= 2.3 Hz),  1.75 (2H, m), 1.56 (2H, m). 
13C-NMR (100MHz CDCl3): δ  174.0 (s),  80.4-73.1 (s), 81.7-75.1 (s),  51.3 (q),  33.3 (t), 27.7 













Methyl 15(S),16(S)dihydroxy-octadeca-6,9,12-trynoate (134) 
 
 
To a suspension consisting of 4mmol of cesium carbonate, 4mmol of sodium iodide, 4mmol of 
cuprous iodide in 10ml of DMF, we added 4mmol of 133. It was left under stirring for 20 
minutes then, 4mmol of 54 were added, leaving under stirring for 20 hours. After adding a 
saturated solution of ammonium chloride, it was extracted with diethyl ether, and anhydrified 
and concentrated under vacuum. The crude reaction was purified on silica gel with an eluent 
consisting of a mixture of petroleum ether and diethyl ether (from 9/1 to 1/1). We obtained 
3.6mmol of 134 (90%). 
 
Methyl 15(S),16(S)dihydroxy-octadeca-6,9,12-trynoate (134) 
1H-NMR (CDCl3, 400 MHz): δ  3.67 (3H, s), 3.60 (1H, bdd, J= 5.7 Hz, J= 6.5 Hz), 3.50 (1H, 
m), 3.15 (2H, bdd, J= 2.1 Hz, J= 2.7 Hz, J= 2.7 Hz), 3.12 (2H, tt, J= 2.1 Hz, J= 2.1 Hz), 2.46 
(2H, ddt, J= 5.7 Hz, J= 2.7 Hz, J= 16.9 Hz), 2.42 (2H, ddt, J= 2.7 Hz, J= 6.5 Hz, J= 16.9 
Hz),  2.31 (2H, t, J= 7.5 Hz), 2.18 (2H, tt, J= 7.1 Hz, J= 2.1 Hz), 1.72 (2H, m), 1.54 (4H, m), 
1.00 (3H, t, J= 7.4 Hz). 
13C-NMR (100MHz CDCl3): δ  174.2 (s), 79.5-73.8 (s), 73.4 (d), 71.6 (d), 50.8 (q), 32.9 (t), 27.5 
(t), 25.9 (t), 23.6 (t), 23.2 (d), 17.8 (t), 9.7 (q), 9.1 (t). 



























To a solution of 3.6mmol of 134 in 10ml of methanol was added a catalytic amount of 
Pd/BaSO4 and a few drops of quinoline. We left react under mild hydrogen pressure for a 
night: the reaction monitored by TLC, was practically quantitative. It was purified on silica 
only to remove the quinoline and the catalyst, eluting with hexane / ethyl acetate 8:2.  
 
 
Methyl 15(S),16(S)-dihydroxyoctadeca-6(Z),9(Z),12(Z)-tryenoate (135) 
1H-NMR (CDCl3, 400 MHz): δ  5.56 (1H, bdt, J= 10.7 Hz, J= 6.4 Hz), δ  5.46 (1H, bdt, J= 
10.7 Hz, J= 7.3 Hz),   5.42-5.32 (4H, m),  3.66 (3H, s), 3.50 (1H, bdt, J= 5.3 Hz, J= 4.6 Hz), 
3.39 (1H, bdd, J= 6.6 Hz, J= 4.6 Hz),  2.85 (2H, dd, J= 6.4 Hz, J= 6.0 Hz), 2.80 (2H, dd, J= 
5.3 Hz, J= 5.2 Hz),  2.33 (2H, bdd, J= 7.5 Hz, J= 6.8 Hz), 2.31 (2H, t, J= 7.4 Hz), 2.06 (2H, 
bdt, J= 5.6 Hz, J= 7.5 Hz), 1.64 (2H, m), 1.61 (1H, m), 1.59-1.51 (2H, m), 1.39 (2H, bt, J= 7.5 
Hz), 0.99 (3H, t, J= 7.4 Hz). 
13C-NMR (100MHz CDCl3): δ  174.2 (s), 131.6 (d), 129.5-127.6 (d), 125.4 (d), 75.0 (d),  73.3 
(d), 33.8 (q), 31.6 (t), 288 (t), 26.3 (t), 25.6 (t), 25.5 (t), 24.4 (t), 9.9 (q), 5.2 (q). 
MS (m/z): 324 (M+) 
















4.8.8 Enzymatic lactonization of methyl 15(S),16(S)-dihydroxyoctadeca-







Aplyolide C (28) Aplyolide E (29)  
 
 
A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of dihydroxy-ester 135 was added to the 
reaction flask and it was immersed in a bath at 40° C for 48h. 
After the reaction, the enzyme was removed from the solution by filtration and concentrated 
under vacuum. The crude was purified on silica and eluted with hexane / chloroform 6 / 4. 
39% of aplyolide E (29) was obtained . 
 
Aplyolide E (29) 
1H-NMR (CDCl3, 400 MHz): δ  5.56 (1H, m),  5.47 (1H, m), 5.39 (2H, m),  5.33 (2H, m),        
4.96 (1H, m),  3.57 (1H, m), 2.89-2.77 (2H, m), 2.58-2.29 (2H, m),  2.41-2.32 (2H, ddd, J= 15.4 
Hz, J= 7.3 Hz, J= 6.6 Hz),  2.20-1.98 (2H, m), 1.73-1.63 (2H, m), 1.45 (8H, m), 1.42 (2H, m), 
0.99 (3H, t, J= 7.5 Hz). 
13C-NMR (100MHz CDCl3): δ  173.2 (s), 131.7-125.0 (d), 128.5 (d), 128.4 (d),  128.1 (d), 75.4 
(d),  74.2 (d), 33.8 (t), 28.0 (t), 26.7 (t), 26.5 (t), 25.7 (t), 25.5 (t), 24.2 (t), 10.0 (q). 
MS (m/z): 292 (M+) 
IR (cm-1): 1730 
[ ] )3.04.40(20 ±+=
D
α   (c=0.4 in CHCl3) 
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4.9 Synthesis of enantiomers of aplyiolides C and E 
Again, we performed Sharpless asymmetric dihydroxylation reaction using the AD-mix-β™ 
to obtain the enantiomers aplyolides C and E .  The obtained Methyl 15(R),16(R)-




















   
A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of dihydroxy-ester 138 was added to the 
reaction flask and it was immersed in a bath at 40° C for 3h. 
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After the reaction, the enzyme was removed from the solution by filtration and concentrated 
under vacuum. The crude was purified on silica and eluted with hexane / chloroform 6 / 4. 
81% of enantiomer of aplyolide C (139) was obtained. 
 
Enantiomer of aplyiolide C (139) 
1H-NMR (CDCl3, 400 MHz): δ  5.64 (1H, m), 5.50 (1H, m), 5.39 (1H, m), 5.37 (1H, m),  5.34 
(2H, m),  4.80 (1H, m),  3.72 (1H, m), 2.86-2.75 (2H, m), 2.48-2.34 (2H, ddd, J= 15.0 Hz, J= 
7.5 Hz, J= 7.3 Hz),  2.32-2.16 (2H, m),  2.06-2.01 (2H, m), 1.80-1.67 (2H, m), 1.74 (2H, m), 
1.46 (2H, m), 0.92 (3H, t, J= 7.5 Hz). 
13C-NMR (100MHz CDCl3): δ  173.4 (s), 131.8 (d), 130.4 (d), 127.7 (d), 124.9 (d), 76.7 (t),  
71.3 (d), 34.1 (t), 32.5 (t), 28.0-27.3 (t), 26.2 (t), 26.0 (t), 24.9 (t), 20.4 (t), 10.0 (q). 
MS (m/z): 292 (M+) 
IR (cm-1): 1720 
[ ] =20Dα + (20.7 ± 0.2)  (c=0.4 in CHCl3) 
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4.10 Lactonization of methyl 15 (R),16(R) –dihydroxy-octadecanoate 







To a solution of 3.6mmol of 138 in 10ml of methanol was added a catalytic amount of 
Pd/BaSO4 and a few drops of quinoline. We left react under mild hydrogen pressure for a 
night: the reaction monitored by TLC, was practically quantitative. It was purified on silica 
only to remove the quinoline and the catalyst, eluting with hexane / ethyl acetate 8:2.  
 
 
Methyl 15(R),16(R)-dihydroxyoctadecanoate (141) 
1H-NMR (CDCl3, 400 MHz): δ  3.66 (3H, s), 3.41 (1H, m), 3.33 (1H, m), 2.29 (2H, t, J= 7.6 
Hz), 1.97 (1H, t, J= 6.8), 1.60 (4H, m), 1.45 (4H, m), 1.27 (20H, m), 0.99 (3H, t, J= 7.4 Hz). 
13C-NMR (100MHz CDCl3): δ  173.1 (s), 78.8 (d), 76.3 (d), 51.9 (q), 33.6 (t), 31.7 (t),  30.0 (t), 




























A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of dihydroxy-ester 141 was added to the 
reaction flask and it was immersed in a bath at 40° C for 24h. 
After the reaction, the enzyme was removed from the solution by filtration and concentrated 
under vacuum. The crude was purified on silica and eluted with hexane / chloroform 6 / 4. 
65% of 142 was obtained. 
 
Compound 142 
1H-NMR (CDCl3, 400 MHz): δ  4.03 (1H, m), 3.80 (1H, m), 2.26 (2H, m), 1.68 (2H, m), 1.57 
(2H, m), 1.32-1.29 (22H, m), 0.99 (3H, t, J= 7.4 Hz). 
13C-NMR (100MHz CDCl3): δ  173.4 (s), 76.7 (d), 73.6 (d), 34.7 (t), 31.2 (t), 27.4 (t), 25.2 (t), 
















144 was prepared by Fisher esterification reaction, performed preparing a solution of 2mmol 
erytro aleiritic acid in 10ml of methanol and acidified with 5 drops of sulfuric acid 96%. 
It leads to reflux at 70° C for 20 hours. After you perform an extraction with diethyl ether 
and water. Ethereal phases were combined, anhydrified on Na2SO4 and concentrated under 
vacuum. The reaction is almost quantitative, but the ester 1 is purified on silica, eluting with 








A solution of 50mg of enzyme (CALB Immobilized on acrylic resin) in 40ml of  cyclohexane 
was prepared. Reaction flask was placed in a chamber containing a saturated solution of salt 
hydrates (Na2HPO4 · 2H20/7H20) and it is left in indirectly contact, under vigorous 
agitation, for 24h. After this time, 0.04mmol of hydroxy-ester 1 was added to the reaction 
flask and it was immersed in a bath at 40° C for 1h. 
After the reaction, the enzyme was removed from the solution by filtration and concentrated 
under vacuum. The crude was purified on silica and eluted with hexane / chloroform 6 / 4. 
We obtained 48% of lactone (145).  
 
Aleuritic lactone (145) 
1H-NMR (CDCl3, 400 MHz): 3.47 (2H, m), 4.13 (2H, t, J= 4.5 Hz), 2.32 (2H, t, J= 6.1 Hz), 
1.81 (2H, -OH), 1.63 (4H, m), 1.39 (20H, m). 
13C-NMR (100MHz CDCl3): δ  173.4 (s), 75.7 (t), 77.2 (2), 67.0 (t), 71.6 (d), 51.3 (q), 34.4 (t), 
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